Spinal stenosis

M13_SPINSTENOSIS

spinal stenosis: Narrowing of the spinal canal.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — M48.0 Hospital discharge: ICD-9 — 7230A\|7240 Cause of death: ICD-10 — M48.0 Cause of death: ICD-9 — 7230A\|7240 2 out of 7 registries used, show all original rules.	26716
4. Check minimum number of events None	26716
5. Include endpoints None	26716
6. Filter based on genotype QC (FinnGen only)	26716

Control definitions (FinnGen only)

Control exclude: M13_DORSOPATHY

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: M48
Name in latin: Stenosis spinalis

NAME	M13_SPINSTENOSIS
CONTROL_EXCLUDE	M13_DORSOPATHY
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	M480
HD_ICD_9	7230A\|7240
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	M480
COD_ICD_9	7230A\|7240
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Spinal stenosis based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	163807	88973	74037
Only index persons	150765	83430	67335
Unadjusted period prevalence (%)
Whole population	2.32	2.55	2.07
Only index persons	2.85	3.07	2.57
Median age at first event (years)
Whole population	66.83	68.57	64.71
Only index persons	66.35	68.15	64.11

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	26716	14148	12568
Unadjusted period prevalence (%)	5.16	4.82	5.54
Median age at first event (years)	65.30	65.05	65.58

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
20718: Matched controls
172729

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

N05CF01

ATC

zopiclone; oral

1.9

323.0

6747

34951

M54.5

ICD-10 Finland

Low back pain

6.9

323.0

9409

18463

M96.1

ICD-10 Finland

Postlaminectomy syndrome, not elsewhere classified

1314.5

323.0

453

M54

ICD-10 Finland

Dorsalgia

3.6

323.0

2376

5981

NAG63

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, more than 3 vertebraea

468.2

323.0

495

R07.4

ICD-10 Finland

Chest pain, unspecified

2.3

323.0

5954

26098

UJF32

NOMESCO Finland

Coloscopy

2.0

323.0

5580

26374

SPAT1153

SPAT

Removal of sutures

2.4

323.0

7766

34850

N02BE01

ATC

paracetamol; systemic, rectal

4.8

323.0

18949

118970

NAG66

NOMESCO Finland

Posterior interbody fusion of lumbar spine, 2 vertebrae

+∞

323.0

509

R42

ICD-10 Finland

Dizziness and giddiness

2.1

323.0

4385

19306

A02BC01

ATC

omeprazole; systemic

2.1

323.0

5903

27805

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

8.6

323.0

4953

6081

A02BC05

ATC

esomeprazole; systemic

2.2

323.0

8741

43540

J01DB01

ATC

cefalexin; oral

2.2

323.0

16461

110408

M03BC51

ATC

orphenadrine, combinations; systemic

2.3

323.0

5733

24828

G55.1*M51.1

ICD-10 Finland

Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions

98.7

323.0

906

NE1AA

NOMESCO Finland

Pelvis X-ray examination

3.7

323.0

1760

4233

M75.1

ICD-10 Finland

Rotator cuff syndrome

2.8

323.0

5763

20809

M01AE01

ATC

ibuprofen; systemic, rectal

2.4

323.0

17889

124665

7227C

ICD-9 Finland

Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[SYNDROMA ISCHIADICUM]

+∞

323.0

1123

N03AX12

ATC

gabapentin; oral

11.9

323.0

6947

6997

N02AJ06

ATC

codeine and paracetamol; systemic

3.4

323.0

9380

33423

M16.1

ICD-10 Finland

Other primary coxarthrosis

3.4

323.0

3306

9199

9211

FHL

Exploration or removal of diskusprolapse

473.3

323.0

715

L13

ICPC

Hip symptom/complaint

2.9

323.0

3842

12526

C07AB07

ATC

bisoprolol; oral

1.8

323.0

10204

60770

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

4.0

323.0

2078

4636

M54.4

ICD-10 Finland

Lumbago with sciatica

15.4

323.0

6767

5271

SPAT1216

SPAT

Assessment of functional ability

2.4

323.0

3452

13315

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

285.5

323.0

3965

143

R06.0

ICD-10 Finland

Dyspnoea

2.3

323.0

5411

23084

M01AX17

ATC

nimesulide; oral

2.4

323.0

5819

24403

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

58.8

323.0

1599

245

M51.9

ICD-10 Finland

Intervertebral disc disorder, unspecified

97.8

323.0

504

M02AA07

ATC

piroxicam; topical

1.9

323.0

7634

40760

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

2.0

323.0

7964

41810

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

366.0

323.0

2561

M47.9

ICD-10 Finland

Spondylosis, unspecified

71.4

323.0

1604

203

I10

ICD-10 Finland

Essential (primary) hypertension

2.0

323.0

13105

80154

L17

ICPC

Foot/toe symptom/complaint

2.3

323.0

5344

23077

ABC66

NOMESCO Finland

Decompression of lumbal spinal channel

1521.6

323.0

375

M01AB05

ATC

diclofenac; systemic, rectal

2.4

323.0

14276

81995

M79.6

ICD-10 Finland

Pain in limb

3.1

323.0

8551

32189

M70.6

ICD-10 Finland

Trochanteric bursitis

4.0

323.0

3074

7164

A06AC01

ATC

ispaghula (psylla seeds); oral

2.1

323.0

5021

23074

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

68.1

323.0

6387

1123

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

2.0

323.0

5294

24825

M01AX05

ATC

glucosamine; oral

2.3

323.0

4809

19845

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

2.8

323.0

2627

8436

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

1395.2

323.0

1803

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

708.4

323.0

6228

104

N03AX16

ATC

pregabalin; oral

9.6

323.0

9598

14252

M54.3

ICD-10 Finland

Sciatica

16.0

323.0

2066

1185

M54.2

ICD-10 Finland

Cervicalgia

6.6

323.0

1578

2127

M01AE02

ATC

naproxen; oral, rectal

2.0

323.0

11191

63343

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

3.4

323.0

11525

46339

A02BC03

ATC

lansoprazole; oral

2.3

323.0

6713

29615

L28

ICPC

Limited function/disability (L)

3.1

323.0

4065

12683

N02AA05

ATC

oxycodone; systemic

3.1

323.0

3938

12310

AB5BT

NOMESCO Finland

Blockage of nerv root with X-ray guidance

556.4

323.0

458

R03AC02

ATC

salbutamol; inhalant

2.0

323.0

10173

57062

C03CA01

ATC

furosemide; systemic

1.9

323.0

6458

32770

ABC60

NOMESCO Finland

Decompression of cervical spinal cord

577.6

323.0

475

M47.82

ICD-10 Finland

Other spondylosis, cervical region

42.9

323.0

1809

384

ABC26

NOMESCO Finland

Open discectomy of lumbar spine

7081.5

323.0

825

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

70.1

323.0

3507

500

M17.1

ICD-10 Finland

Other primary gonarthrosis

2.7

323.0

5402

19976

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

26.5

323.0

5937

2578

M43.1

ICD-10 Finland

Spondylolisthesis

110.4

323.0

2516

216

M50.3

ICD-10 Finland

Other cervical disc degeneration

29.7

323.0

643

186

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

18.7

323.0

1937

949

G99.2*M47.1

ICD-10 Finland

Spondylogenic compression of spinal cord

+∞

323.0

358

L03

ICPC

Low back symptom/complaint

6.1

323.0

7601

15072

72510

ICD-8 Finland

Displacement of intervertebral disk, Lumbalis cum prolapsu disci

+∞

323.0

562

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

6.3

323.0

2131

3091

72880

ICD-8 Finland

Vertebrogenic pain syndrome, Radicula syndrome of lower limbs

+∞

323.0

365

Z01.8

ICD-10 Finland

Other specified special examinations

2.3

323.0

4555

18955

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

2.7

323.0

3325

11593

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.1

323.0

6248

29349

J01AA02

ATC

doxycycline; systemic

1.9

323.0

15747

107881

H02AB06

ATC

prednisolone; systemic

2.1

323.0

9978

53172

A01

ICPC

Pain general/multiple sites

3.6

323.0

1709

4243

L01

ICPC

Neck symptom/complaint

2.8

323.0

2568

8438

N06AX11

ATC

mirtazapine; oral

2.1

323.0

6333

30036

M54.9

ICD-10 Finland

Dorsalgia, unspecified

9.0

323.0

2940

3122

G56.0

ICD-10 Finland

Carpal tunnel syndrome

3.6

323.0

3474

9190

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

53.3

323.0

2547

453

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

3217.4

323.0

1123

ABC30

NOMESCO Finland

Decompression of cervical nerve roots

1504.4

323.0

371

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

22.3

323.0

965

378

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

3.1

323.0

7467

26911

SPAT1301

SPAT

No procedures

1.9

323.0

6353

32123

M01AH02

ATC

rofecoxib; oral

3.0

323.0

3338

10513

M03BX02

ATC

tizanidine; oral

2.9

323.0

13410

67131

7240B

ICD-9 Finland

Other and unspecified disorders of back, Spinal stenosis, other than cervical[STENOSIS CANALIS SPINALIS LUMBOSACRALIS]

+∞

323.0

654

G55.2*M47.9

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

101.2

323.0

704

ABC16

NOMESCO Finland

Microsurgical excision of lumbar intervertebral disc displacement

1093.1

323.0

1350

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

115.2

323.0

7371

824

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

7.0

323.0

1098

1367

NF1AA

NOMESCO Finland

Hip X-ray examination

3.7

323.0

2437

6047

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

13.4

323.0

1103

719

A02BC02

ATC

pantoprazole; systemic

2.4

323.0

14205

81496

M01AC06

ATC

meloxicam; systemic, rectal

2.4

323.0

8462

38110

WX408

NOMESCO Finland

General anesthesy, balanced

2.5

323.0

6621

27340

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

110.1

323.0

389

L86

ICPC

Back syndrome with radiating pain

13.4

323.0

2449

1714

9212

FHL

Other posterior root decompression surgery (eg laminectomy, Gill)

793.7

323.0

466

M48.0

ICD-10 Finland

Spinal stenosis

11255.0

323.0

20272

630

M01AH01

ATC

celecoxib; oral (coxibs)

3.1

323.0

4711

15020

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

3.0

323.0

4314

14113

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

158.4

323.0

804

M48.9

ICD-10 Finland

Spondylopathy, unspecified

238.5

323.0

364

S18

ICPC

Laceration/cut

2.3

323.0

9816

47870

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

10.9

323.0

1155

931

N06CA01

ATC

amitriptyline and psycholeptics; systemic

3.0

323.0

2280

6869

M25.5

ICD-10 Finland

Pain in joint

2.4

323.0

5815

23778

N02AX02

ATC

tramadol; systemic, rectal

5.4

323.0

12992

40810

N06AA09

ATC

amitriptyline; systemic

5.0

323.0

3082

5811

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

3164.9

323.0

2726

M01AH05

ATC

etoricoxib; oral

2.8

323.0

13162

66386

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.1

323.0

6660

31528

B01AB05

ATC

enoxaparin; parenteral

2.0

323.0

6669

33403

N06AX21

ATC

duloxetine; oral

5.7

323.0

3088

5188

M03BC01

ATC

orphenadrine (citrate); systemic

3.3

323.0

5239

16248

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.4

323.0

3732

14344

M54.1

ICD-10 Finland

Radiculopathy

25.5

323.0

1470

515

M47.1

ICD-10 Finland

Other spondylosis with myelopathy

679.7

323.0

786

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.8

323.0

2780

8968

M01AE03

ATC

ketoprofen; systemic, rectal

2.2

323.0

8434

41336

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

26.5

323.0

1427

481

M19.0

ICD-10 Finland

Primary arthrosis of other joints

3.3

323.0

2424

6645

M53.1

ICD-10 Finland

Cervicobrachial syndrome

4.7

323.0

2211

4265

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

19.1

323.0

782

354

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.0

323.0

9635

51918

M43.0

ICD-10 Finland

Spondylolysis

194.7

323.0

700

ACC51

NOMESCO Finland

Release of median nerve

3.4

321.2

1749

4543

XA402

NOMESCO Finland

ENMG

8.1

320.8

782

829

M01AB55

ATC

diclofenac, combinations; oral

3.4

320.5

1749

4550

N06AX16

ATC

venlafaxine; oral

2.7

318.5

2591

8816

ZZH40

NOMESCO Finland

Substitute of bone

19.9

317.7

513

220

NAG65

NOMESCO Finland

Anterior and posterior fusion of lumbar spine

+∞

315.3

324

ZXA00

NOMESCO Finland

Right side

1.9

311.3

5878

29481

M53.2

ICD-10 Finland

Spinal instabilities

173.5

310.7

348

L02

ICPC

Back symptom/complaint

3.4

308.2

1714

4518

AA1AD

NOMESCO Finland

CT of head and brain

2.0

304.9

5031

23940

R51.80

ICD-10 Finland

Headache

2.7

304.2

2446

8249

WX110

NOMESCO Finland

Local anesthesy

1.7

303.6

12804

83121

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.9

301.6

5944

30209

L08

ICPC

Shoulder symptom/complaint

2.1

295.7

3848

16564

N02AC04

ATC

dextropropoxyphene; oral

4.8

295.2

1086

1972

TAB20

NOMESCO Finland

Epidural puncture

37.2

295.0

403

J01DA01

ATC

[U] cefalexin; systemic

1.7

294.8

12190

78302

N03AE01

ATC

clonazepam; systemic

3.7

294.4

1415

3313

M54.6

ICD-10 Finland

Pain in thoracic spine

4.6

293.0

1129

2151

M41.9

ICD-10 Finland

Scoliosis, unspecified

32.0

292.9

414

110

J01MA02

ATC

ciprofloxacin; systemic

1.8

292.1

8030

45518

SPAT1263

SPAT

Sampling

1.8

291.9

8022

45464

M79.1

ICD-10 Finland

Myalgia

2.7

291.7

2352

7934

R52.2

ICD-10 Finland

Other chronic pain

6.4

290.3

837

1135

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

4.9

290.0

1034

1814

SPAT1229

SPAT

Assessment of need for aid

3.0

289.5

1920

5727

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

14.5

289.1

525

310

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.8

283.9

7969

45346

J45.9

ICD-10 Finland

Asthma, unspecified

2.2

281.9

3491

14660

NA3SA

NOMESCO Finland

Lumbar spine X-ray examination in standing position

37.2

279.7

382

ZXM20

NOMESCO Finland

Intraoperative use of computerised tomography

34.3

279.1

388

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.6

277.6

2359

8187

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

3.0

274.6

1748

5063

N04BC05

ATC

pramipexole; oral

3.1

273.3

1738

5032

R4110

NOMESCO Finland

Physiotherapy

1.9

272.6

5510

28051

L15

ICPC

Knee symptom/complaint

2.0

271.2

4096

18686

A02BA02

ATC

ranitidine; systemic

2.0

264.2

4127

19054

J01CA04

ATC

amoxicillin; systemic

1.7

263.6

15083

104726

ZXA05

NOMESCO Finland

Left side

1.9

263.6

5375

27385

WZA90

NOMESCO Finland

Other doctors statement

2.0

263.5

4265

19963

G04CA02

ATC

tamsulosin; oral

1.8

262.5

5572

28776

SPAT1249

SPAT

Treatment-related counselling outside office

1.7

261.7

7418

42027

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.8

261.2

6449

34995

G44.2

ICD-10 Finland

Tension-type headache

2.6

259.4

2188

7544

G55.1

ICD-10 Finland

Nerve root and plexus compressions in intervertebral disc disorders

33.6

258.5

361

A28

ICPC

Limited function/disability NOS

2.2

257.9

3181

13281

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

3.0

257.0

1678

4936

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.8

255.4

5823

30742

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.2

255.4

3021

12370

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

3.7

254.6

1218

2831

C10AA05

ATC

atorvastatin; oral

1.7

253.9

8279

48758

NFB30

NOMESCO Finland

Primary total prosthetic replacement of hip joint not using cement

2.9

253.8

1741

5291

M79.0

ICD-10 Finland

Rheumatism, unspecified

5.8

251.3

776

1148

SAA01

NOMESCO Finland

Simple examination of mouth

1.7

249.8

12501

82771

J01FF01

ATC

clindamycin; systemic

1.8

249.5

5401

27984

SAA02

NOMESCO Finland

Basic examination of mouth

1.6

248.4

11044

70755

G47.3

ICD-10 Finland

Sleep apnoea

1.9

248.3

4424

21403

R60.0

ICD-10 Finland

Localized oedema

2.4

247.8

2395

8875

SPAT1310

SPAT

Counselling related to known health issue

1.8

245.8

6020

32440

C08CA01

ATC

amlodipine; oral

1.7

245.2

7576

43792

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

3.0

244.8

1566

4539

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

14.2

244.1

446

267

A06AD11

ATC

lactulose; oral

2.1

243.5

3105

13124

X59

ICD-10 Finland

Exposure to unspecified factor

2.0

240.2

3489

15572

NAG61

NOMESCO Finland

Posterior fusion of lumbar spine without fixation

+∞

240.2

247

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

13.0

238.4

452

295

R53

ICD-10 Finland

Malaise and fatigue

2.0

237.0

3668

16783

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

4.3

234.8

960

1932

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.4

234.5

2367

8952

N05BA01

ATC

diazepam; systemic, rectal

2.2

232.1

2716

11023

M54.8

ICD-10 Finland

Other dorsalgia

5.4

231.1

752

1185

C10AA01

ATC

simvastatin; oral

1.6

230.6

9431

58594

L84

ICPC

Back syndrome without radiat pain

4.3

230.1

933

1862

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.4

229.8

2302

8666

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.8

228.4

1653

5184

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

3.3

227.5

1261

3292

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

4.3

225.3

925

1868

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.6

225.3

9913

62631

J01FA06

ATC

roxithromycin; oral

1.7

224.9

7600

44739

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.0

222.9

3340

15044

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

4.5

222.9

868

1664

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

5.7

222.4

697

1049

SPAT1212

SPAT

Extensive examination of musculoskeletal system

2.8

221.2

1605

5036

72870

ICD-8 Finland

Vertebrogenic pain syndrome, Lumbalgia

+∞

220.7

227

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

2.9

218.8

1512

4600

WX704

NOMESCO Finland

Intubation

2.8

218.5

1593

5011

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.9

217.1

3599

16837

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.6

217.0

8413

51241

WX402

NOMESCO Finland

General anaesthesia

2.0

215.3

3298

14962

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.1

214.7

2961

12875

R52.9

ICD-10 Finland

Pain, unspecified

2.7

212.6

1599

5126

B01AC04

ATC

clopidogrel; oral

1.9

212.0

3500

16334

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.6

212.0

9227

57785

M01AX01

ATC

nabumetone; oral

3.6

211.5

1054

2527

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.1

211.2

2830

12152

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.8

211.1

4836

25274

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.0

211.0

3153

14157

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

3.2

210.9

1234

3348

M45

ICD-10 Finland

Ankylosing spondylitis

40.2

209.3

281

AB5CT

NOMESCO Finland

Blockage of nerv root with CT guidance

468.4

208.9

223

UKC02

NOMESCO Finland

Cystoscopy

1.9

208.9

3585

16963

M02AA10

ATC

ketoprofen; topical

2.0

207.7

3160

14280

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.0

207.4

3319

15294

N02AJ13

ATC

tramadol and paracetamol; systemic

7.4

207.2

534

615

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.6

205.8

1673

5611

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.7

205.0

5675

31366

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

2.2

203.8

2305

9170

G04BD12

ATC

mirabegron; oral

2.3

203.1

2147

8270

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.0

201.8

3244

14957

G55.1*M51.9

ICD-10 Finland

Nerve root and plexus compressions in intervertebral disc disorders (M50-M51+)

95.5

201.8

238

Z50.1

ICD-10 Finland

Other physical therapy

3.1

201.6

1233

3449

SPAT1325

SPAT

Vaccination

1.6

201.6

6593

38152

NAU20

NOMESCO Finland

Removal of internal fixation device from spine or neck

62.3

201.6

251

NAG41

NOMESCO Finland

Anterior fusion of cervical spine with fixation

78.2

199.6

241

G99.2*M50.0

ICD-10 Finland

Cervical disc disorder with myelopathy

447.0

199.3

213

J01FA10

ATC

azithromycin; systemic

1.6

197.8

9849

63348

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.8

197.3

1396

4301

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

3.1

196.0

1184

3282

C10AA07

ATC

rosuvastatin; oral

1.7

195.6

4992

26862

NA3DG

NOMESCO Finland

Lumbar spine very extensive MRI examination with high intensity magnet

24.4

195.0

295

102

205

Kela drug reimbursment

Chronic hypertension

1.6

193.9

6148

35189

R52.1

ICD-10 Finland

Chronic intractable pain

20.3

193.8

310

129

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.7

193.5

5890

33328

SPAT1254

SPAT

Administration of medicine

2.0

193.5

2764

12147

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.7

193.1

4621

24365

M53.0

ICD-10 Finland

Cervicocranial syndrome

3.0

192.8

1267

3720

M79.7

ICD-10 Finland

Fibromyalgia

5.7

191.8

597

890

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

2.4

191.2

1845

6779

R02

ICPC

Shortness of breath/dyspnoea

2.2

191.2

2247

9080

7245A

ICD-9 Finland

Other and unspecified disorders of back, Backache, unspecified

+∞

190.5

196

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.6

189.9

8032

49468

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.4

188.8

1836

6771

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

22.8

188.5

291

108

R06AE07

ATC

cetirizine; oral

1.6

187.9

7330

44208

G99.2*M47.9

ICD-10 Finland

Myelopathy in spondylosis

284.2

187.5

204

N05BA04

ATC

oxazepam; oral

1.7

187.0

4430

23249

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.6

186.1

8951

56778

G99.2

ICD-10 Finland

Myelopathy in diseases classified elsewhere

128.1

185.9

213

C01DA14

ATC

isosorbide mononitrate; oral

1.9

184.7

3278

15623

R01AD09

ATC

mometasone; nasal

1.6

183.0

7538

45993

K02.1

ICD-10 Finland

Caries of dentine

1.5

183.0

9507

61323

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.7

182.8

4762

25692

TPH04

NOMESCO Finland

Cathetrisation of vein

1.8

182.7

4054

20821

T90

ICPC

Diabetes non-insulin dependent

1.7

182.1

4828

26177

WX308

NOMESCO Finland

Sacral anesthesy

144.5

181.6

206

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

5.6

180.8

571

866

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.9

180.5

3185

15133

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.9

180.0

3279

15754

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.7

179.8

4919

26895

N06AB04

ATC

citalopram; systemic

1.8

178.9

3880

19764

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

3.8

178.7

834

1888

P01AB01

ATC

metronidazole; oral, rectal

1.6

178.4

6999

42118

M48

ICD-10 Finland

Other spondylopathies

70.7

178.3

218

M01AH03

ATC

valdecoxib; oral

2.7

178.0

1356

4365

NF1DA

NOMESCO Finland

X-ray of hips

5.0

177.1

624

1074

R20.2

ICD-10 Finland

Paraesthesia of skin

3.0

176.6

1158

3390

SPAT1260

SPAT

Consultation of another employee

1.9

176.3

3309

16055

L29

ICPC

Musculoskeletal sympt/complt other

2.6

175.7

1456

4920

R5599

NOMESCO Finland

Other rehabilitation service

5.2

175.2

591

969

ABC99

NOMESCO Finland

Other decompressive operation on spinal cord or nerve root

520.2

174.8

186

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.7

173.8

4135

21655

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.4

173.6

1607

5767

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.0

173.5

2673

12060

7221A

ICD-9 Finland

Intervertebral disk disorders, Displacement of thoracic or lumbar intervertebral disk without myelopathy

+∞

173.0

178

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.7

171.6

4485

24144

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.0

171.5

2606

11692

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

2.1

171.4

2329

9991

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.9

170.9

3000

14199

L14

ICPC

Leg/thigh symptom/complaint

2.5

169.8

1440

4925

XKD00

NOMESCO Finland

Uroflowmetry

1.8

168.6

3654

18566

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.1

167.3

2120

8826

Z01.2

ICD-10 Finland

Dental examination

1.6

166.1

6774

40958

R05FA02

ATC

opium derivatives and expectorants; systemic

1.5

165.9

7388

45615

R35

ICD-10 Finland

Polyuria

2.6

165.9

1382

4678

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

165.7

6031

35451

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.5

164.3

1479

5224

M01AC01

ATC

piroxicam; systemic, rectal

1.9

163.8

2707

12517

N06AA10

ATC

nortriptyline; systemic

5.8

163.2

500

730

J02AC01

ATC

fluconazole; systemic

1.6

162.5

6357

37997

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.5

161.7

1403

4856

SPAT1312

SPAT

General health counselling

1.6

161.4

5455

31417

NA3CF

NOMESCO Finland

Lumbar spine extensive MRI examination with median intensity magnet

112.3

161.3

187

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.8

161.3

3536

17999

R05FB02

ATC

cough suppressants and expectorants

1.5

159.0

7203

44521

C08CA13

ATC

lercanidipine; oral

1.9

158.1

2672

12445

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

3.8

158.0

727

1624

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.4

157.8

1535

5639

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.6

157.6

4914

27678

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

5.2

157.4

532

874

D07AC01

ATC

betamethasone; topical

1.6

157.1

6292

37752

M54.0

ICD-10 Finland

Panniculitis affecting regions of neck and back

12.6

156.9

301

202

M01AB08

ATC

etodolac; oral

2.4

156.6

1463

5265

C10AX09

ATC

ezetimibe; oral

2.0

156.3

2302

10176

J01EA01

ATC

trimethoprim; systemic

1.7

155.8

4268

23186

G55.2

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

32.7

155.6

218

R01BA52

ATC

pseudoephedrine, combinations; oral

1.6

155.3

5462

31717

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.7

154.6

1182

3804

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.6

154.5

4610

25635

B01AF01

ATC

rivaroxaban; oral

1.9

154.5

2436

11051

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

2.5

154.1

1366

4778

R07.3

ICD-10 Finland

Other chest pain

2.2

153.8

1687

6569

H02AB04

ATC

methylprednisolone; systemic

1.9

153.7

2720

12866

L12

ICPC

Hand/finger symptom/complaint

2.0

153.6

2386

10761

NA7BT

NOMESCO Finland

Injection to spinal facet joint with radiological guidance

679.4

153.4

162

ABC50

NOMESCO Finland

Decopression of cervical spinal canal and nerve roots

455.1

152.6

163

R05

ICD-10 Finland

Cough

1.8

152.3

3400

17369

E0000UV

ATC

1.5

152.0

6757

41464

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

1.9

151.8

2394

10855

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

2.1

151.4

2023

8589

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

4.1

151.3

650

1365

M01AB51

ATC

indometacin, combinations; oral, rectal

4.2

150.8

623

1261

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.5

150.6

6380

38695

KMAK

NOMESCO Finland

1.5

150.3

8547

55347

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.5

150.3

9611

63800

A46

ICD-10 Finland

Erysipelas

1.8

149.2

2827

13682

L16

ICPC

Ankle symptom/complaint

2.2

148.6

1691

6693

WX320

NOMESCO Finland

Spinalanesthesy

1.6

148.5

4285

23572

SAA03

NOMESCO Finland

Extended examination of mouth

1.5

147.4

6185

37383

NA3BG

SPAT

6.6

146.8

410

530

A10BA02

ATC

metformin; oral

1.6

146.4

5664

33571

N40

ICD-10 Finland

Hyperplasia of prostate

1.6

146.3

4835

27557

A04

ICPC

Weakness/tiredness general

2.0

146.2

2094

9138

R03DC03

ATC

montelukast; oral

1.9

145.0

2569

12136

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

5.2

144.9

484

784

X58

ICD-10 Finland

Exposure to other specified factors

1.9

144.3

2274

10294

ZXC95

NOMESCO Finland

Use of surgical navigator

7.2

143.9

376

442

N05CD07

ATC

temazepam; oral

1.9

143.8

2538

11969

ZXA10

NOMESCO Finland

Bilateral

1.7

143.4

3454

18022

N05CF02

ATC

zolpidem; oral

1.8

143.1

3028

15176

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.4

142.7

1329

4765

N30.0

ICD-10 Finland

Acute cystitis

2.0

142.5

2207

9923

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.9

142.3

2536

12001

M01AB01

ATC

indometacin; systemic, rectal

2.1

142.0

1714

6960

G04BD08

ATC

solifenacin; oral

2.4

141.5

1370

5010

N05AH04

ATC

quetiapine; oral

1.9

141.0

2536

12036

G54.0

ICD-10 Finland

Brachial plexus disorders

6.4

140.7

401

533

NBL00

NOMESCO Finland

Suture or reinsertation of rotator cuff of shoulder

2.5

140.0

1253

4398

E66.01

ICD-10 Finland

Obesity due to excess calories

2.4

139.8

1272

4504

R13

ICD-10 Finland

Dysphagia

2.4

138.4

1275

4545

K59.09

ICD-10 Finland

Constipation, unspecified

2.5

138.1

1167

3970

7231A

ICD-9 Finland

Other disorders of cervical region, Cervicalgia

+∞

137.9

142

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.0

137.6

1897

8142

J01FA09

ATC

clarithromycin; systemic

1.6

137.5

5338

31564

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.1

137.2

1691

6923

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.4

136.7

1258

4482

SPAT1262

SPAT

Handing over of treatment supplies

1.7

136.4

3593

19204

M04AA01

ATC

allopurinol; systemic

1.8

136.2

2774

13712

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

3.0

136.0

867

2481

M09AX01

ATC

hyaluronic acid; parenteral

2.6

135.9

1094

3622

M50.9

ICD-10 Finland

Cervical disc disorder, unspecified

27.3

135.2

198

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.3

134.8

1449

5575

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

4.9

134.4

479

834

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

2.0

133.3

2030

9055

A03FA02

ATC

cisapride; oral, rectal

2.2

133.2

1472

5734

M15

ICD-10 Finland

Polyarthrosis

2.8

132.6

944

2903

M46.9

ICD-10 Finland

Inflammatory spondylopathy, unspecified

177.4

132.5

148

EBA00

NOMESCO Finland

Extraction of tooth

1.5

132.5

5540

33269

M99.3

ICD-10 Finland

Osseous stenosis of neural canal

47.9

131.9

171

AN1

Coronary angiography

1.8

131.8

2466

11841

R05

ICPC

Cough

1.7

131.8

3613

19506

R96

ICPC

Asthma

2.2

131.8

1518

6028

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.9

131.6

2359

11159

SPAT1097

SPAT

Recording of ECG

1.8

131.5

2830

14223

N06AB03

ATC

fluoxetine; oral

1.9

131.4

2167

9951

D07AB02

ATC

hydrocortisone butyrate; topical

1.6

131.4

4847

28254

H25.1

ICD-10 Finland

Senile nuclear cataract

1.6

130.6

4685

27118

TPH07

NOMESCO Finland

Cathetrisation of artery

1.9

130.6

2090

9494

Z71.8

ICD-10 Finland

Other specified counselling

1.6

130.5

3713

20247

SPAT1305

SPAT

Counselling and guidance related to physical exercise

2.1

130.4

1718

7228

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.9

129.8

853

2492

A02BA04

ATC

nizatidine; systemic

2.1

128.1

1553

6306

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

4.5

127.7

495

941

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.6

127.2

4063

22818

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.5

126.8

1102

3803

H02BX01

ATC

methylprednisolone, combinations; systemic

2.5

126.7

1082

3700

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.6

126.3

3903

21726

M41.8

ICD-10 Finland

Other forms of scoliosis

33.4

125.6

175

R01AD08

ATC

fluticasone; nasal

1.6

124.9

4626

26933

G56.2

ICD-10 Finland

Lesion of ulnar nerve

3.5

124.4

633

1536

SPAT1058

SPAT

PEF monitoring instruction

2.1

123.9

1496

6058

R03BB04

ATC

tiotropium bromide; inhalant

1.9

123.7

2059

9476

H02AB07

ATC

prednisone; oral

1.8

123.5

2613

13038

A98

ICPC

Health maint/preventive medicine

1.7

123.5

18626

144844

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.4

123.0

7610

49462

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.9

122.6

1960

8887

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.6

122.5

4531

26351

N06AB10

ATC

escitalopram; oral

1.7

122.2

2868

14770

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.5

122.1

5715

35060

ABD32

NOMESCO Finland

Implantation of temporary spinal stimulation device

17.4

122.0

205

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.8

121.4

2522

12505

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

18.9

121.3

198

NA1AD

NOMESCO Finland

Cervical spine CT examination

3.1

120.9

737

2045

K30

ICD-10 Finland

Functional dyspepsia

2.0

120.4

1666

7141

H04.10

ICD-10 Finland

Dry eye syndrome

2.0

120.3

1643

7005

M48.8

ICD-10 Finland

Other specified spondylopathies

98.6

120.2

141

R03BA01

ATC

beclometasone; inhalant

1.8

120.1

2438

11998

J01MA12

ATC

levofloxacin; systemic

1.6

120.0

3573

19664

S29

ICPC

Skin symptom/complaint other

1.7

119.5

2909

15137

M51.2

ICD-10 Finland

Other specified intervertebral disc displacement

38.6

119.3

161

103

Kela drug reimbursment

Diabetes, insulin-treated

1.5

119.3

5331

32343

R03BA02

ATC

budesonide; inhalant

1.7

118.5

2883

14994

G99.2*M51.0

ICD-10 Finland

Lumbar and other intervertebral disc disorders with myelopathy

159.3

118.3

133

G83.4

ICD-10 Finland

Cauda equina syndrome

39.3

118.2

159

WX002

NOMESCO Finland

Sedation and analgesia

1.6

118.1

3651

20282

J45.1

ICD-10 Finland

Nonallergic asthma

2.3

118.0

1239

4704

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.2

117.9

1264

4847

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.4

117.9

1113

4008

S97

ICPC

Chronic ulcer skin

2.4

117.7

1120

4050

R03BA05

ATC

fluticasone; inhalant

1.7

117.4

2939

15408

C09CA01

ATC

losartan; oral

1.5

117.4

4583

26948

M76.0

ICD-10 Finland

Gluteal tendinitis

6.9

116.2

312

382

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

116.0

3612

20089

Z02.7

ICD-10 Finland

Issue of medical certificate

2.4

116.0

1069

3804

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.8

115.7

2296

11207

NJ3NA

NOMESCO Finland

Measurement of difference in extremity lengty with X-ray

4.2

114.6

471

948

SPAT1053

SPAT

Memory test

1.7

114.3

2795

14544

M09AA72

ATC

quinine, combinations with psycholeptics; systemic

3.0

114.1

715

2022

P01BA02

ATC

hydroxychloroquine; oral

2.1

113.7

1424

5852

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.9

113.3

1835

8348

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

8.4

113.2

268

270

C03AA03

ATC

hydrochlorothiazide; oral

1.9

113.1

1948

9058

Z00.0

ICD-10 Finland

General medical examination

1.6

112.9

3137

16913

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.3

112.8

1105

4054

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.6

112.7

3685

20733

C07AB02

ATC

metoprolol; systemic

1.6

112.4

4003

22998

J01CE02

ATC

phenoxymethylpenicillin; oral

1.4

112.3

12029

85926

N17

ICPC

Vertigo/dizziness

1.9

112.0

1787

8082

NA3BM

NOMESCO Finland

Lumbar spine MRI examination with 3 Tesla magnet

41.4

111.3

148

SPAT1211

SPAT

Application of soft bandage

2.0

110.9

1613

7041

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

3.4

110.5

584

1459

NFC20

NOMESCO Finland

Secondary implantation of hip prosthesis

4.6

110.5

416

768

U02

ICPC

Urinary frequency/urgency

1.8

109.5

2022

9626

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

7.6

109.2

275

306

NBA30

NOMESCO Finland

Exploration of joint of shoulder or upper arm, arthroscopic

3.2

109.2

634

1699

M03BX01

ATC

baclofen; systemic

4.9

109.0

383

657

RF210

NOMESCO Finland

3.5

108.9

556

1352

7228C

ICD-9 Finland

Intervertebral disk disorders, Postlaminectomy syndrome[SYNDROMA LUMBOSACRALE POSTLAMINECTOMIAM]

+∞

108.8

112

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.8

107.8

2298

11459

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.6

107.7

888

2973

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

107.7

2049

9850

M76.8

ICD-10 Finland

Other enthesopathies of lower limb, excluding foot

7.0

107.6

286

345

C10AA04

ATC

fluvastatin; oral

1.9

107.5

1720

7782

XX2CT

NOMESCO Finland

Other injection with CT guidance

115.5

107.4

124

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.8

107.3

2184

10731

A07EC01

ATC

sulfasalazine; oral, rectal

2.1

107.2

1322

5390

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.1

106.9

1280

5156

M01AE11

ATC

tiaprofenic acid; oral, rectal

2.6

106.6

841

2744

-1

NOMESCO Finland

1.5

106.6

5005

30543

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.5

106.5

4090

23874

G04CA01

ATC

alfuzosin; oral

1.7

106.4

2478

12688

XF402

NOMESCO Finland

ECG with work load test

1.8

106.2

2130

10413

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.4

106.2

6962

45380

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.7

106.0

2785

14761

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

4.4

105.4

411

786

R03AK07

ATC

formoterol and budesonide; inhalant

1.6

105.3

3112

17027

M01AE51

ATC

ibuprofen, combinations; systemic

4.7

105.3

387

697

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.9

105.1

1609

7156

G04CB01

ATC

finasteride; oral (testosterone-5-alpha reductase inhibitors)

1.7

105.1

2363

11970

N03AX09

ATC

lamotrigine; oral

3.0

105.0

665

1891

R03AC03

ATC

terbutaline; inhalant

1.8

105.0

2237

11146

A01AB09

ATC

miconazole; local oral

2.0

104.5

1508

6556

TAC99

NOMESCO Finland

Other blockade for chronic pain

11.4

104.5

209

154

M48.1

ICD-10 Finland

Ankylosing hyperostosis [Forestier]

60.6

104.3

130

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.5

104.2

926

3228

E66.8

ICD-10 Finland

Other obesity

2.6

103.8

835

2756

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.8

103.5

1946

9310

M50.8

ICD-10 Finland

Other cervical disc disorders

66.6

103.3

127

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.0

103.0

1384

5848

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.9

102.8

1570

6976

WX290

NOMESCO Finland

Other blockade of nerve

1.4

102.8

6516

42136

M19.9

ICD-10 Finland

Arthrosis, unspecified

2.8

102.6

733

2255

WZA00

NOMESCO Finland

Short statement of of health and health related matters

2.4

102.1

956

3424

M70.7

ICD-10 Finland

Other bursitis of hip

3.8

101.7

475

1073

A02BC04

ATC

rabeprazole; oral

2.0

101.1

1374

5833

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.5

100.8

4513

27203

M76.6

ICD-10 Finland

Achilles tendinitis

3.0

100.7

631

1782

C09CA06

ATC

candesartan; oral

1.5

100.3

3800

22068

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

2.6

100.0

777

2511

J45

ICD-10 Finland

Asthma

1.9

99.7

1519

6740

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.0

99.6

1418

6129

NGB40

NOMESCO Finland

Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis

3.1

99.3

591

1612

SPAT1202

SPAT

Intra-articular injection

2.9

99.2

653

1907

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.5

99.2

4420

26603

A07AA02

ATC

nystatin; oral

2.2

98.9

1121

4400

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.7

98.6

2273

11584

SDA02

NOMESCO Finland

Parodonthologic therapy

1.5

98.2

5165

32155

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.5

97.7

3673

21273

N06AA12

ATC

doxepin; systemic

2.3

97.6

1010

3800

ZZH31

NOMESCO Finland

Bone allograft, small pieces

7.3

97.6

251

289

P20

ICPC

Memory disturbance

1.7

97.3

2103

10508

NA3CM

NOMESCO Finland

Lumbar spine extensive MRI examination with 3 Tesla magnet

36.0

97.3

133

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.6

96.7

3142

17567

K59.0

ICD-10 Finland

Constipation

2.3

96.7

965

3567

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.8

96.6

1985

9760

SDA01

NOMESCO Finland

Simple parodonthologic therapy

1.5

96.6

3694

21472

I20.09

ICD-10 Finland

Unstable angina

2.2

96.4

1128

4492

WX725

NOMESCO Finland

Noninvasive ventilation

2.4

96.2

864

3027

M46.4

ICD-10 Finland

Discitis, unspecified

+∞

96.1

J01CA08

ATC

pivmecillinam; oral

1.4

95.5

5571

35344

L90

ICPC

Osteoarthrosis of knee

2.1

95.3

1160

4698

R01AD12

ATC

fluticasone furoate; nasal

1.5

94.9

4265

25674

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

1.9

94.7

1512

6819

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.6

94.7

2800

15280

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.6

94.4

2869

15763

M19.1

ICD-10 Finland

Post-traumatic arthrosis of other joints

3.2

94.2

540

1433

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.5

94.2

3798

22327

J20

ICD-10 Finland

Acute bronchitis

1.9

94.2

1536

6983

I50.9

ICD-10 Finland

Heart failure, unspecified

1.6

93.7

2526

13445

M46.1

ICD-10 Finland

Sacroiliitis, not elsewhere classified

23.4

93.2

142

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

2.0

93.0

1338

5802

M99.6

ICD-10 Finland

Osseous and subluxation stenosis of intervertebral foramina

46.1

92.9

121

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.0

92.9

1355

5907

A03CA02

ATC

clidinium and psycholeptics; oral

2.1

92.8

1106

4435

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.1

92.8

563

1554

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.7

92.4

2262

11718

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.8

92.3

637

1915

L04AA13

ATC

leflunomide; oral

3.3

92.1

497

1262

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.2

92.0

1054

4154

SPAT1240

SPAT

Therapeutic discussion

2.0

91.7

1277

5468

R33

ICD-10 Finland

Retention of urine

1.9

91.5

1598

7440

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

8.4

91.4

215

M96.0

ICD-10 Finland

Pseudarthrosis after fusion or arthrodesis

14.3

91.3

165

L85

ICPC

Acquired deformity of spine

43.7

91.3

120

R06AX27

ATC

desloratadine; oral

1.5

91.2

3760

22187

L03.0

ICD-10 Finland

Cellulitis of finger and toe

2.1

91.1

1154

4752

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.1

90.0

1129

4630

G04BD04

ATC

oxybutynin; oral, transdermal

2.2

89.8

972

3734

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

2.7

89.6

660

2066

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

2.8

89.2

627

1907

A29

ICPC

General symptom/complaint other

1.8

88.9

1849

9115

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

4.6

88.5

329

600

R60.9

ICD-10 Finland

Oedema, unspecified

2.4

88.4

849

3078

XKC03

NOMESCO Finland

Water cystometry

2.9

88.4

579

1684

M10.9

ICD-10 Finland

Gout, unspecified

2.0

88.3

1295

5652

M35.3

ICD-10 Finland

Polymyalgia rheumatica

2.5

88.0

749

2548

M99.5

ICD-10 Finland

Intervertebral disc stenosis of neural canal

120.8

88.0

101

A11

ICPC

Chest pain NOS

2.0

87.7

1259

5452

B01AX06

ATC

[U] rivaroxaban; oral

3.2

87.6

498

1314

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

2.6

87.5

691

2255

R15

ICD-10 Finland

Faecal incontinence

3.3

87.2

473

1206

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.2

86.7

969

3775

E66.00

ICD-10 Finland

Metabolic syndrome

2.2

86.5

989

3893

N03AF01

ATC

carbamazepine; oral, rectal

2.2

86.3

947

3657

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

2.6

86.2

706

2351

ICD-10 Finland

3.3

86.0

477

1236

NG1DA

NOMESCO Finland

X-ray of knees

4.0

85.7

375

801

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.6

85.6

2640

14527

R5140

NOMESCO Finland

Monitoring the use of the aid

1.7

85.5

1901

9559

M77.1

ICD-10 Finland

Lateral epicondylitis

2.2

85.4

979

3858

A10BH01

ATC

sitagliptin; oral

1.7

85.2

1819

9034

M16

ICD-10 Finland

Coxarthrosis [arthrosis of hip]

2.3

85.2

825

3002

C09AA02

ATC

enalapril; systemic

1.5

84.9

3850

23139

J01MA06

ATC

norfloxacin; oral

1.6

84.8

2248

11885

NFB40

NOMESCO Finland

Primary total prosthetic replacement of hip joint using hybrid technique

2.5

84.8

710

2395

NA7BG

NOMESCO Finland

Spine and spinal cord MRI examination with high intensity magnet

14.3

84.7

153

7225B

ICD-9 Finland

Intervertebral disk disorders, Degeneration of thoracic or lumbar intervertebral disk[DEGEN DISCI INTERVERT THORAC SEU LUMBOSACR CUM INST]

+∞

84.5

R55

ICD-10 Finland

Syncope and collapse

1.7

84.3

1852

9277

R03BA08

ATC

ciclesonide; inhalant

1.9

84.2

1289

5718

G57.3

ICD-10 Finland

Lesion of lateral popliteal nerve

4.7

84.1

308

553

NBG10

NOMESCO Finland

Acromioplastia

2.9

84.1

565

1672

C10AA03

ATC

pravastatin; oral

1.9

84.1

1345

6062

P03

ICPC

Feeling depressed

2.1

83.8

988

3941

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.4

83.7

796

2870

H01

ICPC

Ear pain/earache

1.9

83.7

1391

6357

7225A

ICD-9 Finland

Intervertebral disk disorders, Degeneration of thoracic or lumbar intervertebral disk[DEGENERATIO DISCI INTERVERTEBRALIS THORAC SEU LUMB]

+∞

83.5

M13.9

ICD-10 Finland

Arthritis, unspecified

2.0

83.3

1159

4956

D07AC13

ATC

mometasone; topical

1.4

83.1

4902

31001

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.4

83.1

4283

26402

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

2.3

83.0

824

3036

R4110

SPAT

2.9

82.7

532

1529

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.5

82.6

3126

18053

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.3

82.1

796

2896

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

2.2

81.9

950

3764

F51.0

ICD-10 Finland

Nonorganic insomnia

1.8

81.5

1689

8306

R25.2

ICD-10 Finland

Cramp and spasm

3.6

81.4

401

948

9201

FHL

Anterior decompression surgery (also includes dees)

362.5

81.0

H13

ICPC

Plugged feeling ear

1.5

81.0

3114

18036

SPAT1070

SPAT

Doppler ultrasound examination of blood flow in arteries of lower extremity

3.5

80.9

412

1000

C09DA01

ATC

losartan and diuretics; oral

1.7

80.7

1975

10205

M19.8

ICD-10 Finland

Other specified arthrosis

2.7

80.6

607

1926

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

3.3

80.4

437

1116

S06.0

ICD-10 Finland

Concussion

1.8

80.2

1508

7185

G54.4

ICD-10 Finland

Lumbosacral root disorders, not elsewhere classified

27.2

80.2

117

WX306

NOMESCO Finland

Lumbar epidural anesthesy

2.4

80.2

746

2660

ABC10

NOMESCO Finland

Microsurgical excision of cervical intervertebral disc displacement

186.2

80.1

D01

ICPC

Abdominal pain/cramps general

1.8

79.7

1417

6626

D19

ICPC

Teeth/gum symptom/complaint

1.5

79.4

3875

23595

S22.3

ICD-10 Finland

Fracture of rib

2.0

79.0

1101

4709

M01AE52

ATC

naproxen and esomeprazole; oral

2.8

78.8

564

1736

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

2.0

78.8

1113

4783

M47.8

ICD-10 Finland

Other spondylosis

49.7

78.7

101

L83

ICPC

Neck syndrome

8.1

78.7

189

196

SPAT1252

SPAT

Overall medication plan or its review

1.9

78.7

1244

5580

72898

ICD-8 Finland

Vertebrogenic pain syndrome, Alia definita

+∞

78.6

71312

ICD-8 Finland

Osteo-arthritis and allied conditions, Spondylarthritis lumbalis sive lumbosacralis

+∞

78.6

H03AA01

ATC

levothyroxine sodium; systemic

1.5

78.3

3735

22633

G04BD07

ATC

tolterodine; oral

2.2

78.1

901

3558

NAK10

NOMESCO Finland

Excision of fragment of vertebra, unspecified

349.8

78.1

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.1

78.0

993

4091

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.9

77.7

1301

5956

7214A

ICD-9 Finland

Spondylosis and allied disorders, Thoracic or lumbar spondylosis with myelopathy

+∞

77.7

7227A

ICD-9 Finland

Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[KAULANIKAMAN VÄLILEVYTYRÄ JUURIOIREINEEN]

+∞

77.7

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.0

77.7

1123

4870

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.8

77.6

1444

6853

H02.3

ICD-10 Finland

Blepharochalasis

2.0

77.2

1113

4821

R50.9

ICD-10 Finland

Fever, unspecified

1.6

77.1

2199

11833

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.9

77.1

1342

6227

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.5

77.0

2805

16032

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

2.9

76.7

509

1494

L89

ICPC

Osteoarthrosis of hip

2.5

76.7

646

2184

C03DA01

ATC

spironolactone; oral

1.7

76.0

1927

10046

N06AX03

ATC

mianserin; oral

2.2

75.7

844

3280

7213A

ICD-9 Finland

Spondylosis and allied disorders, Lumbosacral spondylosis without myelopathy

+∞

75.7

SPAT1081

SPAT

Cardiorespiratory global assessment

2.0

75.5

1037

4408

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.9

75.3

1183

5291

L88

ICPC

Rheumatoid/seropositive arthritis

2.5

75.2

621

2077

C07AA05

ATC

propranolol; systemic

1.5

75.1

2817

16197

7244A

ICD-9 Finland

Other and unspecified disorders of back, Thoracic or lumbosacral neuritis or radiculitis, unspecified

+∞

74.7

K07.60

ICD-10 Finland

Snapping jaw

2.6

74.7

591

1930

S21

ICPC

Skin texture symptom/complaint

1.6

74.6

2026

10759

G57.1

ICD-10 Finland

Meralgia paraesthetica

4.6

74.6

276

502

SPAT1360

SPAT

Extensive global examination

1.9

74.5

1264

5811

L60.0

ICD-10 Finland

Ingrowing nail

2.4

74.4

685

2428

NA3BA

NOMESCO Finland

Lumbar spine extensive X-ray examination without contrast

25.6

74.3

110

B01AA03

ATC

warfarin; systemic

1.4

74.2

3765

23058

J46

ICD-10 Finland

Status asthmaticus

3.0

74.2

454

1263

M05BA04

ATC

alendronic acid; oral

1.8

74.0

1291

5992

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

2.7

73.7

555

1762

U05

ICPC

Urination problems other

2.2

73.4

799

3073

C08CA02

ATC

felodipine; oral

1.7

73.1

1757

9015

SPAT1255

SPAT

Intravenous administration of medicine

1.9

72.9

1146

5125

NAW10

NOMESCO Finland

Reoperation for superficial infection in in surgery of spine or neck

+∞

72.8

K59.1

ICD-10 Finland

Functional diarrhoea

2.2

72.5

791

3046

SFA00

NOMESCO Finland

Small filling

1.6

72.5

1971

10465

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

2.3

72.4

740

2763

P06

ICPC

Sleep disturbance

1.8

72.3

1394

6689

NAG42

NOMESCO Finland

Posterior fusion of cervical spine with or without fixation

38.7

72.2

G04CA52

ATC

tamsulosin and dutasteride; systemic

1.6

72.2

1915

10100

C09AA05

ATC

ramipril; oral

1.4

72.1

4660

29821

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

3.5

72.1

365

883

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.9

72.0

480

1413

J01MA14

ATC

moxifloxacin; systemic

1.7

72.0

1520

7507

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.5

71.8

2869

16714

R03AC13

ATC

formoterol; inhalant

2.1

71.6

843

3359

R11

ICD-10 Finland

Nausea and vomiting

1.9

71.5

1125

5032

NA1BA

NOMESCO Finland

Cervical spine extensive X-ray examination without contrast

6.8

71.4

193

240

AWE00

NOMESCO Finland

Reoperation for deep heamorrhage in surgery of the nervous system

38.3

71.3

R01AD01

ATC

beclometasone; nasal

1.6

71.2

2344

13057

R52.0

ICD-10 Finland

Acute pain

2.9

71.2

461

1331

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.8

71.1

1378

6623

S15

ICPC

Foreign body in skin

2.0

71.1

1053

4604

R4120

NOMESCO Finland

Occupational therapy

2.0

71.1

1057

4631

SFA40

NOMESCO Finland

Replacement of krone of tooth

1.4

70.9

3632

22259

72899

ICD-8 Finland

Vertebrogenic pain syndrome, Other and unspecified

+∞

70.9

7210A

ICD-9 Finland

Spondylosis and allied disorders, Cervical spondylosis without myelopathy

+∞

70.9

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.6

70.8

2180

11948

M77.4

ICD-10 Finland

Metatarsalgia

2.2

70.8

795

3101

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

2.4

70.7

652

2311

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.6

70.7

2245

12399

2402

FHL

External neurolysis of the nerve and possible alteration of the pathway (nerve pressure)

3.6

70.6

343

802

M47.81

ICD-10 Finland

Other spondylosis, occipito-atlanto-axial region

16.9

70.5

119

R06.5

ICD-10 Finland

Mouth breathing

1.8

70.5

1412

6858

D07AD01

ATC

clobetasol; topical

1.5

70.4

2570

14667

M65.3

ICD-10 Finland

Trigger finger

2.3

70.4

716

2668

E000001

ATC

1.5

70.2

3141

18732

S22

ICPC

Nail symptom/complaint

2.0

70.2

960

4072

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.3

70.1

6752

46035

M20.1

ICD-10 Finland

Hallux valgus (acquired)

1.8

70.1

1339

6403

SPAT1104

SPAT

Monitoring of emergency patient

1.9

70.1

1133

5118

D11

ICPC

Diarrhoea

1.8

69.9

1356

6518

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.4

69.7

4164

26247

M47

ICD-10 Finland

Spondylosis

7.4

69.7

177

201

NG2AA

NOMESCO Finland

Patella X-ray examination

2.7

69.5

500

1545

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.9

69.4

1114

5016

J31.0

ICD-10 Finland

Chronic rhinitis

1.9

69.3

1111

5001

H26.4

ICD-10 Finland

After-cataract

1.7

69.1

1483

7356

SPAT1231

SPAT

Assessment of adjustments needed in living environment

3.1

69.0

404

1088

A02BX02

ATC

sucralfate; oral

2.2

69.0

743

2841

35399

ICD-8 Finland

Sciatica

5.9

69.0

206

293

N05BA12

ATC

alprazolam; oral

1.7

68.9

1614

8213

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.1

68.9

895

3716

W19

ICD-10 Finland

Unspecified fall

1.7

68.9

1471

7287

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.1

68.8

813

3243

R51

ICD-10 Finland

Headache

2.4

68.6

638

2272

N01

ICPC

Headache

1.9

68.6

1025

4498

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.6

68.5

1809

9524

L11

ICPC

Wrist symptom/complaint

1.9

68.4

1071

4782

M41.5

ICD-10 Finland

Other secondary scoliosis

64.0

68.2

A08

ICPC

Swelling

2.3

68.2

697

2601

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.0

68.1

1007

4399

SPAT1234

SPAT

Support of social functional capacity

2.1

67.4

824

3336

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

2.0

67.2

974

4221

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.7

67.2

1693

8796

K85

ICPC

Elevated blood pressure

1.5

67.1

2494

14280

JN3AD

NOMESCO Finland

Abdominal CT examination

1.8

67.1

1280

6118

Z02.4

ICD-10 Finland

Examination for driving licence

1.4

66.5

4410

28277

NAG53

NOMESCO Finland

Posterior or lateral fusion of thoracic spine with fixation, more than 3 vertebraea

54.0

66.5

RD211

NOMESCO Finland

2.1

66.4

773

3063

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

4.3

66.2

265

522

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

2.2

66.1

740

2883

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.6

66.0

508

1633

SPAT1285

SPAT

Provision of consultation response

2.0

66.0

890

3751

71310

ICD-8 Finland

Osteo-arthritis and allied conditions, Spondylarthritis cervicalis

+∞

66.0

K07

ICPC

Swollen ankles/oedema

2.2

65.9

730

2830

XF400

NOMESCO Finland

ECG with 12 standard connections

1.5

65.9

2881

17080

N39.3

ICD-10 Finland

Stress incontinence

1.9

65.9

1035

4626

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.7

65.8

1452

7260

NGF35

NOMESCO Finland

Plastic operation of joint cartilage of knee

2.4

65.7

599

2111

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.5

65.6

2227

12480

U07

ICPC

Urine symptom/complaint other

2.0

65.5

923

3958

R06AX22

ATC

ebastine; oral

1.5

65.3

2463

14142

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.5

65.3

2486

14302

NB1BG

NOMESCO Finland

Shoulder and humerus MRI examination with high intensity magnet

3.4

65.0

340

844

R32

ICD-10 Finland

Unspecified urinary incontinence

2.8

65.0

459

1401

N06AB06

ATC

sertraline; oral

1.7

64.8

1459

7336

M76.9

ICD-10 Finland

Enthesopathy of lower limb, unspecified

6.0

64.7

192

271

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.2

64.7

684

2596

B01AF02

ATC

apixaban; oral

1.6

64.5

1665

8702

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

3.4

64.5

336

832

SPAT1043

SPAT

Audiometry

1.6

64.4

1747

9253

207

Kela drug reimbursment

Chronic arrhythmias

1.5

64.4

2576

14977

H02

ICPC

Hearing complaint

1.6

64.3

2025

11144

M50.0

ICD-10 Finland

Cervical disc disorder with myelopathy

197.9

64.3

M53.3

ICD-10 Finland

Sacrococcygeal disorders, not elsewhere classified

8.5

64.1

149

147

TAD08

NOMESCO Finland

Sympathetic block on sacral Level

+∞

64.1

Angiography of the heart and coronary arteries

1.8

64.0

1230

5888

NAW00

NOMESCO Finland

Repair of wound dehiscence in surgery of spine or neck

60.2

63.6

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.8

63.6

1294

6311

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.0

63.5

913

3946

ZSA00

NOMESCO Finland

Procedure related to previous procedure classified in chapter A

11.1

63.5

128

D64.9

ICD-10 Finland

Anaemia, unspecified

1.6

63.3

1766

9420

M46.3

ICD-10 Finland

Infection of intervertebral disc (pyogenic)

559.1

63.2

L99

ICPC

Musculoskeletal disease other

3.4

63.2

335

840

-50

ICPC

Medication/prescr/renewal

2.2

63.2

729

2875

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

2.2

63.2

684

2623

M15.8

ICD-10 Finland

Other polyarthrosis

3.5

63.1

313

745

K29.7

ICD-10 Finland

Gastritis, unspecified

2.4

63.1

594

2130

G99.2*M47.0

ICD-10 Finland

Anterior spinal and vertebral artery compression syndromes

+∞

63.1

7233A

ICD-9 Finland

Other disorders of cervical region, Cervicobrachial syndrome (diffuse)

+∞

63.1

L09

ICPC

Arm symptom/complaint

2.3

63.1

610

2217

RF420

NOMESCO Finland

4.0

63.0

268

559

T84.5

ICD-10 Finland

Infection and inflammatory reaction due to internal joint prosthesis

3.6

63.0

307

721

M75.8

ICD-10 Finland

Other shoulder lesions

2.7

62.9

478

1525

R26.2

ICD-10 Finland

Difficulty in walking, not elsewhere classified

4.1

62.9

263

540

SCA01

NOMESCO Finland

Simple analysis and advice of nutrition with regard to dentistry

1.4

62.8

3702

23220

NBB20

NOMESCO Finland

Primary total prosthetic replacement of humero-scapular joint

4.4

62.7

244

468

D82

ICPC

Teeth/gum disease

1.3

62.6

5005

33035

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

2.2

62.5

658

2490

L18

ICPC

Muscle pain

2.4

62.4

549

1901

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.6

62.3

1619

8474

G57.6

ICD-10 Finland

Lesion of plantar nerve

3.1

62.3

368

999

SPAT1106

SPAT

Acupuncture

7.7

62.3

154

168

NAG67

NOMESCO Finland

Posterior interbody fusion of lumbar spine, more than 2 vertebrae

550.7

62.3

7242A

ICD-9 Finland

Other and unspecified disorders of back, Lumbago

+∞

62.1

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.8

62.1

1101

5130

R1250

NOMESCO Finland

Evaluation of functional capability

3.0

62.1

379

1053

XG410

NOMESCO Finland

Flow-volume spirometry

2.1

61.8

717

2838

R21

ICPC

Throat symptom/complaint

1.5

61.8

2157

12158

H53.1

ICD-10 Finland

Subjective visual disturbances

1.9

61.8

921

4037

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.4

61.7

580

2078

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.8

61.7

1184

5663

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.0

61.7

842

3566

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.3

61.5

610

2243

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

2.8

61.4

414

1228

SHA01

NOMESCO Finland

Correction of physiology of bite - simple therapy visit

1.7

61.3

1343

6696

M02AA15

ATC

diclofenac; topical (antiinflammatory prep., non-steroids for topical use)

1.7

61.3

1280

6289

D12

ICPC

Constipation

2.4

61.0

540

1876

R1240

NOMESCO Finland

Social assessment of need and possibilities of rehabilitation

5.5

60.9

193

296

ACC53

NOMESCO Finland

Release of ulnar nerve

4.0

60.7

264

562

A01AB04

ATC

amphotericin B; local oral

2.0

60.7

805

3369

XJH00

NOMESCO Finland

Transanal ultrasonography

1.7

60.7

1264

6203

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

2.7

60.7

446

1396

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.3

60.6

591

2156

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

1.9

60.6

955

4272

RF220

NOMESCO Finland

3.6

60.5

294

689

M53.9

ICD-10 Finland

Dorsopathy, unspecified

11.3

60.2

120

M75.2

ICD-10 Finland

Bicipital tendinitis

2.9

60.1

392

1137

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.4

60.0

3572

22420

R10.2

ICD-10 Finland

Pelvic and perineal pain

3.4

59.8

317

796

M75

ICD-10 Finland

Shoulder lesions

2.2

59.7

646

2475

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

2.1

59.5

741

3021

SPAT1210

SPAT

Application of cast or individual aid

2.2

59.4

651

2510

PE1AT

NOMESCO Finland

Femoral artery PTA

3.7

59.3

277

628

R12

ICD-10 Finland

Heartburn

1.9

59.3

997

4560

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.2

59.3

646

2485

7151F

ICD-9 Finland

Osteo-arthrosis and allied disorders, Osteo-arthrosis, localised, primary[OSTEOARTHROSIS PRIMARIA, POLVI]

2.6

59.3

451

1439

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

10.9

59.2

120

H25.8

ICD-10 Finland

Other senile cataract

1.6

59.2

1849

10140

D07AA02

ATC

hydrocortisone; topical

1.6

59.1

1907

10541

RF120

NOMESCO Finland

4.5

59.1

226

426

M75.5

ICD-10 Finland

Bursitis of shoulder

3.0

59.0

361

1005

C09CA03

ATC

valsartan; oral

1.6

58.8

1567

8254

D01BA02

ATC

terbinafine; oral; topical

1.4

58.5

4401

28710

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.6

58.5

1804

9863

L04

ICPC

Chest symptom/complaint

2.0

58.5

813

3466

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

1.8

58.5

1143

5498

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.8

58.4

1157

5590

UJF30

NOMESCO Finland

Ileoscopy through colon

1.7

58.3

1477

7672

ABC53

NOMESCO Finland

Decompression of thoracic spinal canal and nerve roots

137.9

58.3

NBG00

NOMESCO Finland

Plastic operation on acromioclavicular joint

3.6

58.2

282

659

G04BD11

ATC

fesoterodine; oral

2.4

58.2

521

1819

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.8

58.1

1122

5374

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.4

57.5

531

1884

M03BB53

ATC

chlorzoxazone, combinations excl. psycholeptics; oral

3.8

57.3

258

567

XF404

NOMESCO Finland

Ambulatory ECG

1.6

57.1

1529

8059

M01AG02

ATC

tolfenamic acid; oral, rectal

1.5

57.1

2065

11718

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.6

57.1

1843

10186

WX720

NOMESCO Finland

Own respiration

2.2

57.0

625

2409

S70.0

ICD-10 Finland

Contusion of hip

2.3

57.0

554

2019

C10AC01

ATC

colestyramine; oral

2.6

57.0

432

1378

9242

FHL

Other reconstruction or plastic surgery of shoulder joint (including ac joint)

3.3

56.9

307

781

A10AE04

ATC

insulin glargine; parenteral

1.6

56.9

1595

8510

J01MA01

ATC

ofloxacin; systemic

1.6

56.9

1506

7915

M50

ICD-10 Finland

Cervical disc disorders

6.9

56.8

150

181

UJD02

NOMESCO Finland

Gastroscopy

2.0

56.8

806

3463

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.5

56.8

480

1627

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1.6

56.7

1513

7968

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.6

56.7

1766

9674

C02AC05

ATC

moxonidine; oral

2.0

56.6

819

3548

ABC63

NOMESCO Finland

Decompression of thoracic spinal cord

35.8

56.6

F34.1

ICD-10 Finland

Dysthymia

2.5

56.4

461

1535

M40.1

ICD-10 Finland

Other secondary kyphosis

108.7

56.2

D07CC01

ATC

betamethasone and antibiotics; topical

1.5

56.2

2033

11537

K29

ICPC

Cardiovascular sympt/complt other

2.0

56.0

732

3045

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.8

56.0

995

4639

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

2.5

55.7

482

1654

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

1.9

55.7

883

3954

A97

ICPC

No disease

1.5

55.7

2227

12919

NDG60

NOMESCO Finland

Arthroplasty of first CMC joint

3.6

55.6

269

629

G04CB02

ATC

dutasteride; oral

1.7

55.4

1264

6371

71700

ICD-8 Finland

+∞

55.3

A05

ICPC

Feeling ill

2.2

55.2

619

2411

S01

ICPC

Pain/tenderness of skin

2.1

55.2

645

2559

1220

FHL

Arthroscopy

2.1

55.1

642

2543

C05AA08

ATC

fluocortolone; rectal, topical

1.5

55.0

2277

13304

J05AB01

ATC

aciclovir; systemic

1.4

54.9

3092

19181

D06

ICPC

Abdominal pain localized other

1.8

54.8

1055

5051

R06.2

ICD-10 Finland

Wheezing

2.1

54.7

642

2553

R01AD11

ATC

triamcinolone; nasal

1.7

54.6

1309

6691

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.3

54.6

547

2022

NB1CG

NOMESCO Finland

Shoulder and humerus extensive MRI examination with high intensity magnet

2.9

54.5

355

1030

UJH02

NOMESCO Finland

Anoscopy

2.1

54.5

673

2735

78559

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD

2.3

54.4

528

1922

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.8

54.3

975

4558

H29

ICPC

Ear symptom/complaint other

1.6

53.9

1525

8151

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.0

53.9

752

3210

E66.9

ICD-10 Finland

Obesity, unspecified

2.4

53.8

488

1718

Z01.9

ICD-10 Finland

Special examination, unspecified

1.9

53.8

869

3917

SPAT1101

SPAT

Orthostatic test

2.0

53.7

724

3050

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.5

53.5

1840

10313

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.5

53.5

458

1563

M41.2

ICD-10 Finland

Other idiopathic scoliosis

87.8

53.4

NA2AD

NOMESCO Finland

Thoracic spine CT examination

8.0

53.3

128

134

C08CA05

ATC

nifedipine; systemic

1.7

53.2

1110

5447

R06AX13

ATC

loratadine; oral

1.5

53.1

2018

11569

SPAT1304

SPAT

Counselling and guidance related to ageing

1.7

53.0

1085

5293

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

3.5

53.0

268

649

L57.0

ICD-10 Finland

Actinic keratosis

1.6

53.0

1634

8923

NBF25

NOMESCO Finland

Operation for humeroscapular osteochondritis, arthroscopic

2.7

53.0

388

1212

A99

ICPC

Disease/condition unspecnature/site

1.7

53.0

1221

6171

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

2.0

52.9

717

3026

D01AC02

ATC

miconazole; topical

1.6

52.9

1353

7040

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.8

52.8

984

4658

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.0

52.8

714

3010

S01GX01

ATC

cromoglicic acid; ophthalmic

1.4

52.7

2531

15224

WX200

NOMESCO Finland

Interscalenous plexus blockade

2.8

52.7

355

1054

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.1

52.7

646

2618

N07BA03

ATC

varenicline; oral

2.0

52.6

726

3086

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.5

52.4

1948

11110

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

2.8

52.3

355

1058

M19.2

ICD-10 Finland

Other secondary arthrosis

3.8

52.2

237

525

1221

FHL

Arthroscopy and meniscus surgery

2.3

52.2

534

1994

R39.1

ICD-10 Finland

Other difficulties with micturition

2.3

52.2

529

1968

S80.0

ICD-10 Finland

Contusion of knee

1.9

52.0

831

3733

R03AK08

ATC

formoterol and beclometasone; inhalant

2.2

51.8

554

2113

A06AC51

ATC

ispaghula, combinations; systemic

1.9

51.6

757

3295

RF410

NOMESCO Finland

3.9

51.5

225

482

I20.00

ICD-10 Finland

Unstable angina

2.2

51.4

573

2226

H92.0

ICD-10 Finland

Otalgia

2.1

51.4

620

2494

D07XC01

ATC

betamethasone, combinations; topical

1.5

51.3

1979

11378

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

2.0

51.3

692

2914

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

1.8

51.2

977

4660

NA3AA

SPAT

3.2

51.1

283

735

U04

ICPC

Incontinence urine

2.0

51.1

676

2827

R5110

SPAT

2.5

51.0

443

1524

M01AC02

ATC

tenoxicam; systemic, rectal

1.9

51.0

846

3848

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.5

50.9

1811

10224

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

2.0

50.9

731

3157

SPAT1167

SPAT

Insertion of urinary catheter

2.1

50.8

584

2302

NDM40

NOMESCO Finland

Discission of sheath of tendon of wrist or hand

2.5

50.7

422

1419

M18.0

ICD-10 Finland

Primary arthrosis of first carpometacarpal joints, bilateral

3.4

50.6

267

669

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

1.8

50.5

1006

4864

NHL16

NOMESCO Finland

Tenolysis or tenosynovectomy of achilles tendon

11.1

50.5

101

A03

ICPC

Fever

1.5

50.4

1848

10505

T82

ICPC

Obesity

2.3

50.4

503

1857

R51.81

ICD-10 Finland

Facial pain NOS

3.0

50.2

304

840

J01DA06

ATC

[U] cefuroxime; systemic

1.5

50.2

2243

13293

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

1.8

50.2

980

4711

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.6

50.1

1525

8300

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

2.9

50.1

329

961

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

2.7

50.0

374

1184

M51

ICD-10 Finland

Other intervertebral disc disorders

10.1

50.0

105

J01FA01

ATC

erythromycin; systemic

1.5

49.9

1749

9838

N41.1

ICD-10 Finland

Chronic prostatitis

2.5

49.9

407

1353

XF600

NOMESCO Finland

Bloodpressure measurement

1.8

49.7

972

4673

S76

ICPC

Skin infection other

1.9

49.6

817

3707

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.7

49.5

1108

5551

72830

ICD-8 Finland

Vertebrogenic pain syndrome, Radicular syndrome of upper limbs

+∞

49.5

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.8

49.5

876

4075

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

3.1

49.4

295

809

N07CA01

ATC

betahistine; oral

1.7

49.4

1199

6149

P76

ICPC

Depressive disorder

2.0

49.3

651

2719

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.7

49.2

358

1115

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.6

49.1

1361

7231

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.6

49.1

1350

7157

A10BH05

ATC

linagliptin; oral

1.9

49.0

814

3704

R30.0

ICD-10 Finland

Dysuria

2.3

49.0

501

1871

D06AX01

ATC

fusidic acid; topical (antibiotics for topical use)

1.6

48.9

1396

7474

9183

FHL

Posterolateral spondylodesis

56.5

48.8

U01

ICPC

Dysuria/painful urination

1.8

48.8

901

4250

AB3CB

NOMESCO Finland

Lumbar myelography

433.1

48.8

K10.3

ICD-10 Finland

Alveolitis of jaws

2.2

48.7

533

2055

J01FA15

ATC

telithromycin; oral

1.6

48.7

1508

8237

ABD99

NOMESCO Finland

Other operation on spinal cord or nerve for pain or impaired function

16.7

48.7

J45.8

ICD-10 Finland

Mixed asthma

2.4

48.5

455

1628

J37.0

ICD-10 Finland

Chronic laryngitis

2.2

48.4

502

1887

M01AB16

ATC

aceclofenac; oral

2.1

48.3

563

2232

N29

ICPC

Neurological sympt/complt other

2.8

48.3

331

992

XX9CW

NOMESCO Finland

Submitting image material and/or investigation material to patient

4.5

48.3

180

332

FN1AT

NOMESCO Finland

Endovascular dilatation of coronary arteries (PTCA)

1.8

48.2

903

4280

VALMI

NOMESCO Finland

1.4

48.2

3321

21269

L84

ICD-10 Finland

Corns and callosities

2.2

48.0

537

2090

N07BC02

ATC

methadone; systemic

11.4

48.0

L05

ICPC

Flank/axilla symptom/complaint

1.9

48.0

769

3458

A02BA03

ATC

famotidine; systemic

2.0

48.0

647

2725

M10.0

ICD-10 Finland

Idiopathic gout

2.1

47.9

574

2303

R09

ICPC

Sinus symptom/complaint

1.8

47.9

873

4102

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

1.7

47.9

1014

4995

M51.0

ICD-10 Finland

Lumbar and other intervertebral disc disorders with myelopathy

93.6

47.8

D02

ICPC

Abdominal pain epigastric

1.9

47.8

750

3346

M42.0

ICD-10 Finland

Juvenile osteochondrosis of spine

79.4

47.8

M21.4

ICD-10 Finland

Flat foot [pes planus] (acquired)

2.4

47.8

421

1459

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.5

47.8

1884

10873

N06AX26

ATC

vortioxetine; oral

2.1

47.7

606

2491

R74

ICPC

Upper respiratory infection acute

1.4

47.7

3272

20936

K86

ICPC

Hypertension uncomplicated

1.5

47.7

1960

11412

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.6

47.7

1327

7055

R06AE09

ATC

levocetirizine; oral

1.5

47.6

1922

11147

N03A

ATC

ANTIEPILEPTICS

20.2

47.6

7230A

ICD-9 Finland

Other disorders of cervical region, Spinal stenosis of cervical region[STENOSIS CANALIS SPINALIS CERVICALIS]

+∞

47.6

3540A

ICD-9 Finland

Mononeuritis of upper limb and mononeuritis multiplex, Carpal tunnel syndrome

3.6

47.5

226

522

M20.2

ICD-10 Finland

Hallux rigidus

2.2

47.5

538

2106

XG466

NOMESCO Finland

Sleep oxymetry

2.1

47.4

570

2288

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

1.5

47.4

1565

8681

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

1.8

47.4

867

4078

I20.90

ICD-10 Finland

Angina pectoris, unspecified

2.0

47.4

653

2773

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

1.6

47.3

1315

6990

C09BA02

ATC

enalapril and diuretics; systemic

1.6

47.3

1529

8438

72410

ICD-8 Finland

Internal derangement of joint, Other shoulder derangement

2.2

47.2

536

2102

AN2

Balloon angioplasty, including several vessels

2.1

47.2

543

2142

G04BD09

ATC

trospium; oral

2.4

47.1

414

1432

ZSN00

NOMESCO Finland

Procedure related to previous procedure classified in chapter N

5.8

47.1

142

206

SPAT1281

SPAT

Other administrative function

1.6

47.0

1188

6158

I65.2

ICD-10 Finland

Occlusion and stenosis of carotid artery

2.4

46.9

407

1401

K29.3

ICD-10 Finland

Chronic superficial gastritis

2.2

46.8

524

2043

SGB10

NOMESCO Finland

Fiiling of rooth of tooth with one root channel

1.5

46.8

1794

10290

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

2.8

46.7

330

1008

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

1.3

46.7

5522

38203

G20

ICD-10 Finland

Parkinson disease

2.1

46.6

574

2330

AAK10

NOMESCO Finland

Repair of dura

28.0

46.6

S54

ICPC

Skin, Repair/fix-suture/cast/prosth device

2.2

46.6

502

1920

J04AB02

ATC

rifampicin; systemic

3.4

46.6

237

578

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.3

46.5

444

1604

AEA24

NOMESCO Finland

Removal of spinal stimulation elecrode

12.8

46.4

A10BB12

ATC

glimepiride; oral

1.6

46.4

1323

7078

D07BC01

ATC

betamethasone and antiseptics; topical

1.5

46.4

1946

11377

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.8

46.3

872

4138

NBL22

NOMESCO Finland

Myotomy, tenotomy or excision of tendon of upper arm

2.9

46.2

293

837

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.9

46.2

683

2979

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.6

46.0

1401

7619

TQW40

SPAT

2.2

45.8

519

2032

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.9

45.7

715

3185

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.8

45.7

784

3610

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

1.9

45.6

724

3243

SPA00

NOMESCO Finland

Changing form of teeth in prepation for prothetic work

1.9

45.6

745

3374

M67.4

ICD-10 Finland

Ganglion

1.8

45.5

868

4137

R31

ICD-10 Finland

Unspecified haematuria

1.5

45.5

1746

10015

XKD03

NOMESCO Finland

Urethral pressure profilometry

2.5

45.5

380

1282

K03.64

ICD-10 Finland

Dental calculus supragingival

1.3

45.3

3704

24336

C09DA06

ATC

candesartan and diuretics; oral

1.6

45.2

1253

6652

N31.9

ICD-10 Finland

Neuromuscular dysfunction of bladder, unspecified

4.3

45.1

177

344

G03CA04

ATC

estriol; systemic, vaginal

1.8

45.1

843

3992

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.5

45.1

1664

9460

WYA10

NOMESCO Finland

First aid or other corresponding healthcare contact

1.7

45.0

1011

5067

M53.8

ICD-10 Finland

Other specified dorsopathies

8.6

45.0

103

100

NFB50

NOMESCO Finland

Primary total prosthetic replacement of hip joint using cement

2.9

45.0

297

872

N06AB05

ATC

paroxetine; oral

1.8

45.0

844

4003

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

1.7

45.0

963

4760

D07AB08

ATC

desonide; topical

1.5

44.9

1541

8620

D20

ICPC

Mouth/tongue/lip symptom/complaint

2.0

44.8

584

2425

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.3

44.8

433

1575

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

4.1

44.8

184

374

NA3CG

SPAT

6.4

44.6

124

162

N30.9

ICD-10 Finland

Cystitis, unspecified

1.9

44.5

744

3394

PEF23

NOMESCO Finland

Thrombendarterectomy of femoral artery

2.7

44.5

329

1036

N02BE51

ATC

paracetamol, combinations excl. psycholeptics; systemic

3.5

44.4

222

534

NB1AD

NOMESCO Finland

Shoulder CT examination

3.0

44.4

279

793

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.7

44.4

1090

5603

N28

ICPC

Limited function/disability (N)

2.9

44.4

286

826

R07.0

ICD-10 Finland

Pain in throat

1.9

44.1

707

3178

J02AC02

ATC

itraconazole; systemic

1.4

44.0

2765

17412

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

1.7

43.8

989

4964

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

2.7

43.8

313

965

7261X

ICD-9 Finland

Peripheral enthesopathies and allied syndromes, Rotator cuff syndrome of shoulder and allied disorders[MUU TAI TARKEMMIN MÄÄRITTELEM KIERTÄJÄKALVOSINSDR]

4.0

43.8

185

386

SPF00

NOMESCO Finland

Repatation of teeth prosthesis

2.2

43.7

470

1797

NAG99

NOMESCO Finland

Other excision, reconstruction or fusion of joints of spine, unspecified

+∞

43.7

S04

ICPC

Lump/swelling localized

1.6

43.6

1260

6764

R03AC12

ATC

salmeterol; inhalant

1.9

43.5

702

3163

S19

ICPC

Skin injury other

2.0

43.4

589

2488

N04BC04

ATC

ropinirole; oral

3.3

43.3

232

589

F32

ICD-10 Finland

Depressive episode

2.0

43.2

579

2434

K08.80

ICD-10 Finland

Toothache NOS

1.7

43.2

971

4866

K05.30

ICD-10 Finland

Periodontitis complex

1.4

43.1

1993

11871

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

2.8

43.1

304

929

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

2.1

43.0

533

2168

NAK30

NOMESCO Finland

Osteotomy of spine

382.7

43.0

R25.1

ICD-10 Finland

Tremor, unspecified

2.2

43.0

445

1673

A10BK03

ATC

empagliflozin; oral

1.6

43.0

1173

6201

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.3

43.0

423

1551

M17.3

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3016502) Oxygen saturation in Arterial blood

4120

17270

2.03

323.31

6.5

7.9

95.8

95.4

3.23

3959

16645

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

3571

14374

2.10

311.39

2.7

2.2

5.8

8.2

ug/l

8.77

3032

12422

(3002173) Hemoglobin [Mass/volume] in Arterial blood

3824

15849

2.04

308.13

6.9

8.3

120.5

120.6

g/l

0.05

3680

15307

(3044889) 12 lead EKG panel

18172

117475

1.69

307.75

4.9

3.8

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

18994

118569

1.93

307.65

4.4

3.8

15.1

14.9

pmol/l

8.89

17175

105955

(3013707) Erythrocyte sedimentation rate by Westergren method

20134

116412

2.53

307.65

5.3

3.8

13.9

13.5

mm/h

2.49

18807

106125

(3037467) Urinalysis macro (dipstick) panel - Urine

18488

109717

2.09

307.65

5.6

4.1

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

24388

171619

2.64

307.65

25.1

17.1

4.0

mmol/l

42.13

24029

166353

(3006315) Basophils [#/volume] in Blood

13801

77436

1.84

307.65

6.1

5.6

0.0

e9/l

1.59

12059

65557

(3023368) Bacteria identified in Blood by Culture

9153

46737

1.82

307.65

4.7

4.3

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

8290

39901

1.92

307.65

2.6

2.2

3.0

3.1

mg/l

0.17

7172

33567

(3029937) Albumin [Presence] in Urine by Test strip

7951

40640

1.77

307.65

5.5

3.8

0.0

estimate

1.59

2279

13526

(3018418) pH of Serum or Plasma

9146

49076

1.71

307.65

4.2

4.1

7.4

0.50

1532

9668

(3031040) Bacteria [#/volume] in Urine by Automated count

18571

104835

2.33

307.65

6.1

4.2

1253.7

1392.7

e6/l

0.13

204

1724

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

6832

31794

1.92

307.65

1.8

1.7

1.2

1.5

mg/l

11.65

5436

24779

(3035350) Ketones [Presence] in Urine by Test strip

13526

75821

1.82

307.65

4.8

3.5

0.0

estimate

0.36

2322

14126

(40761535) Cells panel - Urine sediment

3335

12517

2.25

307.65

4.4

3.3

—

(3019309) Folate [Moles/volume] in Red Blood Cells

6956

32136

1.95

307.65

1.9

1.8

1210.5

1144.9

nmol/l

6.66

5296

23810

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

13051

69268

1.95

307.65

2.3

2.0

95.1

94.9

pmol/l

0.17

6771

35767

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

9766

49049

1.89

307.65

2.8

2.5

56.8

60.4

u/l

4.81

9024

44889

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

23781

160209

2.77

307.65

21.2

14.3

24.5

26.5

mg/l

16.26

20556

126703

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

10610

48626

2.19

307.65

2.5

2.0

218.2

222.9

u/l

0.14

9949

45293

(3009261) Glucose [Presence] in Urine by Test strip

13661

77138

1.81

307.65

4.8

3.5

0.0

estimate

0.45

2287

13932

(3024561) Albumin [Mass/volume] in Serum or Plasma

13314

72302

1.90

307.65

4.8

34.9

g/l

0.45

12307

66704

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

22454

152914

2.05

307.65

7.5

6.0

41.2

40.3

mmol/mol

31.23

20860

139266

(3027801) Oxygen [Partial pressure] in Arterial blood

4581

19426

2.03

307.65

6.3

7.5

12.2

12.3

kpa

0.70

4355

18511

(3013650) Neutrophils [#/volume] in Blood by Automated count

15446

90797

1.81

307.65

8.4

9.2

4.4

4.2

e9/l

14.60

13650

78138

(3044640) Blood type and Crossmatch panel - Blood

10546

51121

2.03

307.65

2.6

2.4

—

(3042936) Bacteria identified in Isolate by Culture

5063

22587

1.94

307.65

2.3

2.0

—

(3021960) Folate [Moles/volume] in Serum or Plasma

7818

38742

1.83

307.65

1.7

1.5

20.7

20.3

nmol/l

1.17

6681

32702

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

22104

146188

2.18

307.65

5.5

4.5

2.1

2.2

mu/l

0.23

20232

131164

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

15291

83664

2.04

307.65

7.1

6.7

1.2

mmol/l

3.77

13130

69647

(3007853) Bacteria identified in Skin by Aerobe culture

4260

17918

2.03

307.65

2.0

1.8

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

14192

75769

2.02

307.65

6.4

6.0

1.2

mmol/l

3.40

12896

68001

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

5843

26473

1.94

307.65

2.0

1.8

—

(3013115) Eosinophils [#/volume] in Blood

14182

79886

1.85

307.65

6.2

5.8

0.2

e9/l

13.06

12492

68609

(3019150) Specific gravity of Urine by Refractometry

6831

31518

1.94

307.65

5.6

3.9

1.0

kg/l

0.14

955

5094

(3021601) Nitrite [Presence] in Urine by Test strip

13460

76241

1.79

307.65

6.1

4.8

0.0

estimate

0.18

2353

14316

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

20513

127109

2.22

307.65

8.0

7.6

78.9

80.8

u/l

5.93

19444

118850

(3026008) Bacteria identified in Urine by Culture

9931

48831

1.96

307.65

3.9

3.0

—

(3032080) INR in Blood by Coagulation assay

13056

70421

1.90

307.65

9.2

9.6

1.2

1.3

inr

6.14

3382

19464

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

5127

20919

2.14

307.65

1.3

1.2

10.6

16.5

u/ml

3.24

1877

7582

(3015736) pH of Urine

10817

58669

1.76

307.65

4.6

3.3

5.5

5.8

—

(3003396) Base excess in Arterial blood by calculation

4562

19458

2.01

307.65

6.3

7.4

1.2

1.0

mmol/l

3.35

3556

15404

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

14937

85830

1.85

307.65

5.7

6.5

10.8

12.1

umol/l

28.34

14174

81264

(3019198) Lymphocytes [#/volume] in Blood

13943

79072

1.82

307.65

6.1

5.6

1.9

e9/l

0.68

12340

68137

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

4587

19439

2.03

307.65

6.3

7.5

5.1

kpa

3.02

4363

18532

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

5427

22374

2.14

307.65

1.3

1.2

36.6

45.6

iu/ml

1.40

1675

7213

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

8255

38834

1.97

307.65

2.6

2.4

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

11188

61229

1.75

307.65

3.1

2.7

135.4

158.6

ug/l

14.77

10170

55784

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

11357

64186

1.68

307.65

2.5

2.1

79.5

78.8

nmol/l

1.76

10078

56478

(3013826) Glucose [Moles/volume] in Serum or Plasma

17589

96345

2.31

307.65

5.3

4.7

6.8

6.9

mmol/l

4.67

16874

90297

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

10516

50702

2.04

307.65

3.3

3.0

1343.7

1653.2

ng/l

12.09

9183

43580

(3019550) Sodium [Moles/volume] in Serum or Plasma

24378

171164

2.67

307.65

25.0

16.9

139.5

139.7

mmol/l

44.30

24033

166192

(3011397) Hemoglobin [Presence] in Urine by Test strip

7406

35311

1.90

307.65

4.9

3.4

—

(3026493) Urate [Moles/volume] in Serum or Plasma

8629

42980

1.85

307.65

2.9

2.7

3901.2

5559.6

umol/l

3.18

7306

36842

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

12094

63050

1.93

307.65

4.8

3.5

52.4

73.5

ng/l

1.39

9370

45708

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

15139

73713

2.44

307.65

4.7

3.9

—

(3001604) Monocytes [#/volume] in Blood

13735

76972

1.84

307.65

6.0

5.6

0.6

e9/l

1.20

11994

65128

(40761511) CBC panel - Blood by Automated count

23747

167016

2.22

301.31

20.1

13.7

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

4577

20373

1.92

300.17

9.8

7.0

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

4151

17972

1.96

294.80

1.9

1.7

—

(3019060) Gas panel - Arterial blood

2858

10776

2.21

292.94

4.7

4.9

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

4128

17935

1.95

289.75

1.9

1.7

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

9967

55999

1.64

288.39

3.0

3.6

2.4

mmol/l

0.61

8511

48184

(3009508) Creatinine [Moles/volume] in Urine

9633

53683

1.64

287.73

3.3

3.2

7.1

7.4

mmol/l

8.43

8021

44390

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

10255

58183

1.63

284.07

5.3

3.7

—

(3019069) Monocytes/100 leukocytes in Blood

12423

73855

1.60

283.93

6.7

6.1

8.7

8.8

2.07

11562

68618

(3012516) Albumin [Mass/volume] in Urine

9473

52719

1.64

283.32

3.4

3.2

602.3

319.4

mg/l

5.09

6121

32912

(3000850) Epithelial cells [#/volume] in Urine

6727

34259

1.72

281.18

2.8

2.6

4.8

5.1

e6/l

1.34

5921

29779

(3006504) Eosinophils/100 leukocytes in Blood

12337

73485

1.60

277.26

6.4

5.8

3.0

2.8

6.10

11457

67996

(3018010) Neutrophils/100 leukocytes in Blood

12399

74243

1.59

269.78

6.3

5.7

58.1

0.03

11502

68891

(3008152) Bicarbonate [Moles/volume] in Arterial blood

2672

10121

2.19

269.62

7.3

24.9

24.5

mmol/l

5.08

2500

9446

(3022096) Basophils/100 leukocytes in Blood

12004

71434

1.58

267.29

6.4

5.9

0.7

0.30

11129

66147

(3002030) Lymphocytes/100 leukocytes in Blood

12555

75557

1.58

265.88

6.5

5.9

26.6

26.8

1.35

11594

69764

(42870588) Differential panel, method unspecified - Blood

9611

54346

1.61

264.54

5.9

5.7

—

(3018095) Leukocytes [#/volume] in Urine

10126

57992

1.60

264.26

4.3

3.6

100.6

121.5

e6/l

1.35

7638

41001

(3020682) Albumin/Creatinine [Ratio] in Urine

9812

55847

1.60

262.18

4.0

9.9

9.0

mg/mmol

0.86

6245

34917

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

22858

160121

1.93

261.93

5.7

4.7

6.1

6.0

mmol/l

23.07

20803

143979

(3020564) Creatinine [Moles/volume] in Serum or Plasma

24255

173665

2.27

260.73

24.6

17.2

81.4

80.3

umol/l

4.71

24247

173582

(3030467) Casts [#/volume] in Urine by Automated count

8389

46188

1.62

255.27

3.7

3.1

0.4

0.5

e6/l

1.97

6619

34357

(36304419) Bacteria [Presence] in Urine

8114

44323

1.63

254.78

3.7

3.0

—

(3033658) Prothrombin time (PT) actual/Normal

7720

42152

1.62

239.65

4.2

4.0

89.0

87.8

3.70

7491

41215

(3037522) Nuclear Ab [Titer] in Serum

3989

18228

1.84

235.61

1.3

511.4

545.7

titre

0.53

847

3970

(3004588) Protein electrophoresis panel - Serum or Plasma

2782

11258

2.05

234.85

2.3

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

24132

173679

2.12

230.07

13.1

10.4

25.7

26.1

u/l

2.11

23383

166302

(3022217) INR in Platelet poor plasma by Coagulation assay

4792

23460

1.73

223.17

27.2

26.6

1.4

inr

2.18

589

3251

(40768797) Stomach Pathology biopsy report

4420

21238

1.76

219.38

1.3

1.2

—

(3002582) Erythrocytes [#/volume] in Urine

8843

50678

1.55

218.55

3.8

3.2

92.1

108.4

e6/l

0.36

7047

38438

(3022948) Iron [Moles/volume] in Serum or Plasma

5190

26181

1.69

215.85

2.6

2.5

12.2

12.6

umol/l

2.91

4725

24150

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

6578

35450

1.61

210.07

1.8

1.7

29692013.8

29762877.2

pmol/l

0.00

5382

28667

(3020630) Protein [Mass/volume] in Serum or Plasma

3160

13867

1.89

209.86

2.5

2.6

66.3

66.2

g/l

0.32

2817

12550

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

5474

28262

1.65

207.24

1.3

1.2

1.3

2.0

u/ml

4.04

1493

7091

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

5477

28362

1.65

204.58

3.2

2.7

1.2

1.3

e6/l

0.16

3404

15861

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

6095

32448

1.61

203.62

4.7

3.6

262.6

609.9

ng/l

10.70

5139

26769

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

5843

30853

1.62

201.48

2.9

3.3

2.5

mmol/l

0.68

5084

26832

(3007461) Platelets [#/volume] in Blood

24579

179379

2.19

200.81

31.3

21.2

248.2

245.8

e9/l

6.82

24165

173276

(3010813) Leukocytes [#/volume] in Blood

24588

179512

2.19

199.82

31.4

21.2

7.0

6.7

e9/l

39.95

24115

172703

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

2888

12496

1.91

199.51

2.7

2.8

63.3

61.6

ml/min/173m2

1.52

1222

4965

(3035941) MCH [Entitic mass]

24578

179453

2.18

198.80

31.2

21.1

30.5

30.4

14.17

24310

176001

(3026361) Erythrocytes [#/volume] in Blood

24580

179494

2.18

198.31

31.4

21.2

4.4

4.5

e12/l

167.91

24101

172621

(3024731) MCV [Entitic volume]

24579

179485

2.18

198.28

31.2

21.2

91.9

91.4

59.28

24310

176025

(3000963) Hemoglobin [Mass/volume] in Blood

24580

179535

2.18

197.33

31.5

21.3

132.2

134.9

g/l

147.87

24301

176105

(4010399)

2616

11003

1.96

196.28

1.5

1.4

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

23054

165198

1.78

189.36

6.0

5.1

2.6

2.7

mmol/l

114.15

21164

149978

(3012095) Magnesium [Moles/volume] in Serum or Plasma

5217

27210

1.63

187.08

2.8

3.4

0.8

mmol/l

1.89

4778

25343

(3027945) Reticulocytes/100 erythrocytes in Blood

4028

19676

1.71

185.40

2.2

2.5

1.8

1.03

3508

17294

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2669

11515

1.91

185.20

1.7

1.6

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

2832

12461

1.88

185.04

2.2

2.4

357.7

384.8

nmol/l

8.84

2556

11462

(3000475) Leukocytes [#/volume] in Synovial fluid

1159

3569

2.62

183.07

1.7

1.6

13286.7

14958.2

e6/l

0.62

845

2564

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

15298

100445

1.46

182.07

3.6

3.0

58.1

53.7

u/l

4.41

14143

92110

(3004789) Transferrin [Mass/volume] in Serum or Plasma

4756

24400

1.64

181.41

2.6

2.5

2.3

g/l

7.23

4345

22447

(3014007) Fractional oxyhemoglobin in Arterial blood

2519

10731

1.93

181.33

7.3

9.5

93.9

93.8

0.46

2507

10691

(3023520) Reticulocytes [#/volume] in Blood

3187

14655

1.80

180.51

2.3

2.6

69.3

68.6

e9/l

0.55

2470

11057

(3003458) Phosphate [Moles/volume] in Serum or Plasma

4371

22065

1.66

177.08

5.1

5.9

1.0

mmol/l

0.59

4000

20470

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

2503

10731

1.91

176.55

7.3

9.3

1.4

1.3

6.65

2480

10655

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

2492

10721

1.91

173.81

7.3

9.4

0.7

6.36

2473

10647

(3014576) Chloride [Moles/volume] in Serum or Plasma

4291

21703

1.66

172.01

6.7

7.2

104.2

104.5

mmol/l

4.58

4183

21226

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

22548

161443

1.68

171.72

5.3

4.6

4.5

4.6

mmol/l

91.41

20765

147284

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

4476

22929

1.64

170.52

2.6

21.2

22.3

5.90

3680

19578

(3020891) Body temperature

1669

6268

2.16

168.96

5.0

4.9

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

2738

12255

1.84

168.59

3.6

3.9

92.1

96.3

ng/l

1.44

2358

10397

(40758558) Short blood count panel - Blood

7053

40251

1.51

167.36

6.3

7.1

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

3137

14797

1.75

161.68

3.2

2.8

201.6

243.1

ng/l

5.12

2886

13532

(3014111) Lactate [Moles/volume] in Serum or Plasma

3148

14882

1.75

160.94

5.9

7.2

1.3

1.4

mmol/l

0.95

3020

14320

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

2184

9229

1.93

160.08

1.5

1.4

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

22316

160067

1.62

158.07

5.2

4.5

1.4

1.5

mmol/l

24.02

20424

145115

(3043409) Potassium [Moles/volume] in Arterial blood

1356

4802

2.28

158.04

4.4

4.5

3.9

mmol/l

1.22

1306

4467

(3018405) Lactate [Moles/volume] in Arterial blood

1517

5641

2.18

157.13

4.2

1.3

1.4

mmol/l

1.78

1494

5541

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1193

4088

2.35

149.82

1.4

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

21662

154740

1.56

149.77

4.7

4.1

1.4

1.3

mmol/l

57.78

19619

139128

(3026782) Osmolality of Urine

5857

32876

1.51

146.97

3.1

2.7

525.6

553.5

mosm/kgh2o

20.34

4988

27844

(3018677) aPTT in Platelet poor plasma by Coagulation assay

4845

26161

1.55

145.12

2.0

29.8

30.0

1.15

4695

25400

(3048689) Calprotectin [Mass/mass] in Stool

3071

14963

1.69

139.35

1.9

2.1

161.3

152.1

ug/g

0.40

2395

11600

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2240

9999

1.83

137.69

1.8

1.6

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

21664

155626

1.52

134.51

18.6

14.0

74.8

76.7

ml/min/173m2

34.41

18665

127714

(3000494) Fungus identified in Specimen by Culture

3542

18092

1.62

133.25

1.5

1.4

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

917

2950

2.49

131.93

1.7

1.5

—

(3007164) IgA [Mass/volume] in Serum or Plasma

4653

25455

1.53

129.47

1.5

2.5

2.6

g/l

0.72

2689

14820

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1292

4870

2.13

128.77

1.3

1.2

1.0

0.9

u/ml

0.08

167

358

(3000991) Gas panel - Venous blood

2890

14323

1.65

121.77

7.1

8.5

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

12542

82811

1.36

119.51

2.5

2.4

—

(40760892) CBC W Ordered Manual Differential panel - Blood

5537

31837

1.46

119.28

4.7

4.4

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2039

9273

1.78

117.04

8.2

10.0

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

8167

50626

1.38

114.24

3.3

3.2

34.5

36.1

u/l

0.95

7724

47733

(3013512) EKG study

8273

51487

1.38

112.53

4.8

3.9

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1410

5796

1.96

110.75

2.4

2.3

379.4

647.3

ug/l

3.64

1321

5479

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

2239

10621

1.71

110.64

3.9

3.6

5.2

5.1

kpa

3.23

2057

9767

(3009343) pH of Capillary blood

2214

10487

1.71

109.96

3.9

3.6

7.4

0.35

257

1374

(3047181) Lactate [Moles/volume] in Blood

1244

4919

2.03

108.94

6.0

6.2

1.3

1.4

mmol/l

2.41

1103

4342

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1976

9127

1.75

107.20

2.5

2.4

40.8

26.0

au/ml

1.98

474

(3044941) Cell count panel - Synovial fluid

720

2290

2.50

105.94

1.5

1.4

—

(3039000) Anion gap in Blood

967

3518

2.20

105.01

6.3

7.3

10.9

11.3

mmol/l

3.55

868

3181

(3018572) Chloride [Moles/volume] in Blood

967

3519

2.20

104.94

6.3

7.3

104.8

105.2

mmol/l

1.52

868

3182

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

2130

10114

1.71

104.62

3.9

3.6

1.9

1.8

mmol/l

0.47

1623

7544

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1511

6480

1.88

104.43

2.2

7.5

7.4

g/l

0.35

1085

4793

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1505

6456

1.88

103.92

2.2

3.7

3.9

g/l

3.04

1048

4589

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1508

6475

1.88

103.82

2.2

—

(3012544) pH of Venous blood

3133

16440

1.56

103.00

3.7

3.8

7.4

0.36

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1425

6047

1.90

101.66

2.3

2.2

3.0

3.1

g/l

3.73

1061

4698

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

4703

26918

1.45

101.46

3.4

2.9

2.8

2.4

e6/l

1.77

2680

14508

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1798

8222

1.77

100.75

1.3

66.6

51.8

au/ml

1.14

397

(3002032) Base excess in Venous blood by calculation

3016

15783

1.56

100.14

3.8

2.0

1.9

mmol/l

0.93

2476

12903

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

3679

20119

1.50

99.73

3.5

4.3

245.2

247.2

u/l

0.26

3430

19042

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1171

4678

2.01

99.54

1.3

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

3015

15798

1.56

99.50

3.7

3.8

5.9

5.8

kpa

4.39

2938

15340

(3021589) Normoblasts [#/volume] in Blood

10865

71454

1.33

99.08

11.0

9.7

0.0

e9/l

0.62

9109

58019

(3021788) Differential panel - Synovial fluid

803

2771

2.31

98.80

1.6

1.5

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1877

8752

1.73

98.18

2.6

2.4

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1402

6078

1.85

93.44

2.2

9.7

10.4

g/l

7.30

1135

5058

(3045414) Leukocytes [Presence] in Urine

1498

6632

1.82

93.33

2.1

1.8

—

(3008898) HLA-B27 [Presence]

792

2832

2.23

89.59

1.1

1.0

—

(3026470) Cobalt [Mass/volume] in Blood

400

1020

3.10

88.80

2.1

1.9

4.1

3.7

ug/l

0.34

340

908

(3024354) Oxygen [Partial pressure] in Venous blood

2491

12846

1.57

87.42

3.2

3.1

4.5

4.6

kpa

0.44

2406

12409

(3014765) Yersinia sp identified in Stool by Organism specific culture

984

3867

2.03

87.37

1.2

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

983

3878

2.02

86.36

1.2

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1946

9477

1.66

86.24

7.4

9.4

24.3

mmol/l

0.14

1795

8850

(3034860) Kappa light chains.free [Mass/volume] in Serum

1280

5534

1.85

85.90

3.0

3.2

48.6

58.7

mg/l

1.53

1074

4473

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1275

5525

1.85

84.93

3.0

3.1

37.1

45.4

mg/l

1.89

1074

4465

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

970

3836

2.02

84.63

1.2

1.1

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1076

4420

1.95

84.29

1.5

1.4

267.9

260.0

ug/g

0.63

650

2648

(3025577) Chromium [Mass/volume] in Blood

384

992

3.06

83.43

2.1

2.0

2.4

2.3

ug/l

0.12

323

827

(3019225) pH of Specimen

3174

17415

1.49

83.38

4.7

4.2

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1244

5381

1.85

83.31

3.0

3.1

2.1

6.6

ratio

1.64

112

391

(3022313) Gas panel - Capillary blood

1627

7631

1.71

82.89

4.2

3.7

—

(3005719) IgG [Mass/volume] in Serum or Plasma

2150

10842

1.60

82.73

2.9

2.7

10.0

10.8

g/l

11.42

1941

9901

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1261

5494

1.84

82.53

2.4

0.8

1.0

g/l

0.56

1068

4632

(3007930) Methemoglobin/Hemoglobin.total in Blood

1491

6853

1.75

81.60

5.5

5.1

0.9

3.47

1382

6454

(3005322) IgE [Units/volume] in Serum or Plasma

1614

7596

1.71

81.16

1.3

216.0

269.9

u/ml

1.69

1471

7014

(3025941) Bacteria identified in Stool by Culture

1602

7537

1.71

80.64

1.3

1.2

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1510

6995

1.73

80.36

5.4

5.1

1.7

1.6

4.18

1405

6593

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

3288

18357

1.46

78.74

2.6

2.7

7.5

10.1

umol/l

7.75

2859

16066

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1493

6933

1.73

78.73

1.3

1.6

9.6

17.4

u/ml

1.22

191

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

982

4002

1.96

78.66

1.6

1.8

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

3201

17796

1.47

78.31

4.0

3.4

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1415

6488

1.75

78.01

4.5

3.9

25.1

24.9

mmol/l

1.48

1297

5949

(40768804) Tissue Pathology biopsy report

10045

66827

1.29

77.47

2.2

2.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

461

1375

2.66

77.21

1.4

78565.2

133295.2

e6/l

1.34

322

935

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

285

641

3.51

77.11

1.5

1.4

5.7

6.5

u/l

0.57

241

536

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

566

1880

2.39

75.85

1.6

1.5

58.6

60.1

0.34

346

1212

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1614

7744

1.67

75.40

2.9

2.7

1.3

1.2

5.84

1605

7704

(3020779) Urea [Moles/volume] in Serum or Plasma

2895

15932

1.48

74.30

6.2

7.2

10.8

10.6

mmol/l

0.72

2713

15095

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1159

5080

1.82

74.28

2.1

37.8

37.3

g/l

2.08

982

4275

(3022145) Colonoscopy Study observation

3222

18104

1.45

74.27

1.3

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1576

7588

1.67

72.58

2.8

2.7

0.7

0.17

1497

7326

(40760888) Immunoglobulin light chains.free panel - Serum

977

4113

1.89

71.02

3.2

—

(3002385) Erythrocyte distribution width [Ratio]

18292

131906

1.29

69.79

24.5

17.9

14.0

13.8

33.47

18011

128681

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1479

7078

1.68

69.63

2.1

1.9

2.2

2.3

ug/l

0.11

1264

6236

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1646

8118

1.63

68.90

1.6

g/l

1.69

1414

6880

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1094

4830

1.81

68.40

2.1

2.2

0.0

g/l

0.11

987

4363

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

2677

14737

1.47

68.21

2.7

2.4

43.7

50.0

u/l

0.33

2276

12624

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1282

5967

1.72

66.82

2.8

2.6

—

(3003338) MCHC [Mass/volume]

18312

132483

1.28

65.04

28.5

18.8

331.3

331.9

g/l

14.10

18170

131293

(3004119) Hemoglobin [Mass/volume] in Venous blood

1964

10289

1.54

63.32

3.4

3.3

126.3

128.0

g/l

2.73

1920

10076

(3037756) Immunofixation for Serum or Plasma

861

3645

1.88

61.47

1.5

1.6

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

1213

5697

1.70

61.10

1.3

1.4

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1437

7057

1.63

61.00

2.1

1.9

—

(3017732) Neutrophils [#/volume] in Blood

1973

10435

1.52

60.78

3.2

3.1

4.1

e9/l

0.05

1454

7645

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1011

4521

1.78

60.51

2.2

0.0

g/l

0.08

906

4071

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1566

7883

1.59

60.05

3.9

4.1

24.2

24.1

mmol/l

0.81

1364

7135

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

995

4464

1.78

58.88

2.2

0.0

g/l

0.00

903

4062

(36660697) Celiac disease serology panel - Serum

1960

10424

1.51

58.75

1.2

—

(21494755) Public health laboratory ask at order entry panel

784

10925

0.55

58.22

1.4

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1322

6439

1.64

57.93

1.9

1.7

—

(3017181) Myelocytes/100 leukocytes in Blood

2437

13591

1.45

57.48

3.9

4.0

0.9

1.0

0.48

708

4112

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1139

5347

1.70

57.42

1.5

1.6

179.4

263.0

titre

0.58

242

(1761868) Lipid panel - Serum or Plasma

5865

55385

0.78

55.98

3.3

3.1

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

775

3280

1.88

55.37

1.4

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1801

9532

1.52

55.11

1.2

—

(3009542) Hematocrit [Volume Fraction] of Blood

19617

144060

1.27

55.02

22.4

15.8

38.7

39.3

10.69

11909

98013

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1660

8647

1.54

54.67

3.0

3.4

4.3

4.4

pmol/l

4.14

1424

7672

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

574

2202

2.07

54.33

6.6

5.9

12.3

11.8

mg/l

1.93

525

2004

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

847

3710

1.82

54.26

1.3

1.2

20.0

41.1

u/ml

2.03

220

(3052851) Hemolysis interference index of Serum or Plasma

1048

4889

1.71

54.03

3.5

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1908

10277

1.49

53.61

6.0

7.2

25.0

24.7

mmol/l

2.03

1890

10168

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

412

1393

2.34

53.15

1.5

29.4

28.3

0.21

258

884

(3022621) pH of Urine by Test strip

1933

10483

1.48

52.46

3.6

2.9

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1257

6209

1.62

51.98

1.9

39.8

38.9

u/l

0.76

1099

5351

(3002179) Metamyelocytes/100 leukocytes in Blood

2204

12296

1.44

51.62

3.8

3.9

0.6

0.7

0.07

494

2988

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

7659

51098

1.25

51.44

4.8

4.3

22.1

22.0

0.25

3822

26226

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1483

7644

1.55

51.13

4.1

4.0

51.0

46.9

8.77

1470

7559

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

9437

64444

1.23

50.93

5.4

5.1

2.6

3.7

ug/l

5.33

8492

57411

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

3001

17704

1.37

50.82

1.4

1.3

—

(3044927) Protein electrophoresis panel - Urine

457

1649

2.19

50.61

1.2

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

784

3437

1.81

50.08

1.3

1.2

3.9

7.1

u/ml

2.42

129

555

(3028026) IgM [Mass/volume] in Serum or Plasma

1632

8646

1.51

49.56

1.9

1.3

1.4

g/l

0.50

1461

7815

(3003181) Sodium [Moles/volume] in Urine

692

2945

1.86

48.60

1.4

1.3

59.1

61.7

mmol/l

1.05

554

2319

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

906

4183

1.72

48.46

1.5

1.2

g/l

1.13

855

3957

(3021440) Promyelocytes/100 leukocytes in Blood

2279

12940

1.42

48.30

4.0

0.2

0.1

1.00

640

3837

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

771

3404

1.80

48.12

1.3

1.2

5.0

5.1

u/ml

0.03

356

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

674

2863

1.87

47.62

1.5

1417.8

2600.2

e6/l

0.67

572

2286

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

673

2859

1.87

47.53

1.4

18.8

36.2

e6/l

1.31

542

2158

(3020961) Endomysium IgA Ab [Titer] in Serum

1125

5528

1.62

47.47

1.1

131.3

256.0

titre

1.30

157

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1077

5244

1.64

47.14

1.1

6.8

4.7

u/ml

0.18

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

745

3276

1.80

47.12

1.4

1.3

718.2

582.9

mg/l

1.34

707

3114

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

2754

16208

1.37

47.10

2.0

2.2

0.2

g/l

0.38

2525

15023

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

876

4053

1.72

46.50

1.5

0.2

g/l

0.05

827

3813

(3025159) Blasts/100 leukocytes in Blood

2130

12033

1.42

46.36

4.0

4.1

0.2

0.3

0.08

542

3242

(4034850)

1006

4841

1.65

46.10

13.3

10.1

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

1568

8378

1.50

45.61

3.5

3.4

25.3

25.2

mmol/l

0.84

1524

8159

(3041096) Erythrocytes [Presence] in Urine by Automated

6219

40991

1.25

45.34

4.1

3.3

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

582

2401

1.92

44.95

1.3

1.5

—

(3014051) Protein [Presence] in Urine by Test strip

752

3368

1.77

44.73

2.5

2.1

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

670

2898

1.83

44.71

1.3

1.2

5.4

5.0

u/ml

0.07

219

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

672

2916

1.83

44.39

1.3

1.2

1.9

11.9

u/ml

1.34

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

6635

44172

1.24

43.88

1.7

1.6

1.4

1.3

mmol/l

10.96

5583

36301

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

875

4113

1.69

43.83

1.6

—

(3026389) Candida sp identified in Specimen by Organism specific culture

487

1907

2.02

43.67

1.5

1.3

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

2561

15085

1.37

43.35

1.6

1.5

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

522

2110

1.96

42.81

2.2

2.1

27.3

27.6

mg/l

0.03

127

577

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

253

765

2.61

41.46

1.8

—

(40757494) Bilirubin.total [Moles/volume] in Blood

263

811

2.56

41.43

2.2

2.1

20.0

27.2

umol/l

0.51

(3000492) Spirometry study

2311

13517

1.37

40.75

1.6

1.5

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

651

2882

1.79

40.29

1.3

1.2

3.9

3.8

mmol/l

0.33

604

2710

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1006

5019

1.59

39.82

1.9

1.6

—

(21494890) Protein electrophoresis panel - 24 hour Urine

441

1726

2.02

39.64

1.8

2.0

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

690

3136

1.74

39.04

1.2

64.4

116.9

titre

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

500

2059

1.92

38.87

1.2

1.3

0.3

nmol/l

0.07

165

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

499

2055

1.92

38.79

1.2

1.3

2.3

2.1

nmol/l

0.04

475

1975

(3015235) Bicarbonate [Moles/volume] in Capillary blood

888

4331

1.63

38.58

2.8

3.1

25.0

24.8

mmol/l

0.85

790

3791

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

922

4544

1.61

38.39

1.3

1.4

14.5

15.9

iu/ml

0.14

105

(3013166) Neutrophils/100 leukocytes in Synovial fluid

166

418

3.13

37.91

1.3

1.4

56.1

58.1

0.25

140

365

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

981

11654

0.65

37.66

1.9

—

(3024263) Appearance of Synovial fluid

244

763

2.52

37.41

1.6

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

586

2597

1.79

36.17

1.3

1.2

37.1

46.1

u/ml

0.64

273

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

2555

15444

1.33

36.08

1.9

1.7

1.6

1.5

9.49

2163

13284

(3037121) Protein [Mass/volume] in Urine

1109

5788

1.52

35.96

3.0

3.2

0.4

0.3

g/l

0.55

433

2558

(40768443) Skin Pathology biopsy report

1349

7330

1.47

35.93

1.2

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

441

1789

1.95

35.86

1.3

—

nmol/l

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1182

6342

1.48

33.53

2.7

2.8

0.3

u/ml

0.07

672

3617

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

231

745

2.44

33.26

1.1

1.9

8.1

nmol/l

2.04

161

(46235355) HIV 1 and 2 tests - Meaningful Use set

2569

15728

1.31

32.97

1.5

1.6

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

176

498

2.78

32.87

2.2

1.9

59.0

54.5

ug/l

0.42

171

487

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

141

352

3.15

32.73

1.4

1.2

32.0

37.3

0.74

242

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

736

3570

1.63

32.70

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

735

3569

1.63

32.52

1.4

1.3

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1137

6095

1.48

32.40

1.1

1.0

—

(3004616) Nuclear Ab [Presence] in Serum

420

1741

1.90

32.09

1.3

—

(3049717) Cytology report of Urine Cyto stain

1309

7230

1.44

31.95

2.6

2.8

—

(44806118)

401

1641

1.93

31.84

1.5

—

(44790047)

401

1642

1.93

31.79

1.5

—

(44790048)

401

1642

1.93

31.79

1.5

—

(44790049)

401

1642

1.93

31.79

1.5

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

792

3955

1.59

31.24

1.5

1.6

9.8

7.4

iu/ml

0.13

211

847

(3011985) Renin [Units/volume] in Plasma

469

2041

1.82

30.80

1.3

1.4

60.9

62.6

mu/l

0.08

413

1796

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

442

1891

1.85

30.66

1.2

1.3

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

391

1612

1.91

30.40

2.9

—

(3044290) Cell count panel - Cerebral spinal fluid

589

2749

1.69

30.36

1.4

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

171

498

2.70

30.30

1.8

1.5

83.6

103.4

umol/l

0.65

100

247

(3045424) Erythrocytes [Presence] in Urine

563

2597

1.71

30.29

1.5

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

755

3756

1.59

30.27

1.5

1.6

—

(3003327) Ova and parasites identified in Stool by Light microscopy

809

4093

1.57

30.18

1.7

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

212

689

2.42

30.08

1.4

1.2

179.0

435.1

u/l

2.82

196

640

(3027456) Digoxin [Moles/volume] in Serum or Plasma

764

3820

1.58

29.99

3.4

3.1

0.8

nmol/l

0.02

584

2988

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

605

2858

1.67

29.81

1.4

—

(3017704) Immunofixation for Urine

253

898

2.22

29.38

1.5

—

(3014271) Vancomycin [Susceptibility]

263

951

2.18

29.19

3.5

2.9

—

(3023419) Bacteria identified in Sputum by Culture

464

2051

1.79

28.97

2.2

2.4

—

(3036670) Protein [Mass/volume] in Synovial fluid

164

482

2.68

28.59

1.3

1.2

42.1

39.4

g/l

1.49

254

(3023183) Ammonium ion [Moles/volume] in Plasma

715

3562

1.59

28.51

2.2

2.6

33.3

34.4

umol/l

0.38

576

3016

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

536

2481

1.71

28.50

1.3

1.4

—

(3009015) Lactate [Moles/volume] in Synovial fluid

149

4.22

28.30

1.3

1.2

6.2

7.0

mmol/l

0.40

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

767

3907

1.55

27.79

1.5

1.6

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

319

1267

1.98

27.68

1.5

1.6

24.9

26.4

u/ml

0.18

273

(3028626) Oxygen [Partial pressure] in Capillary blood

737

3729

1.56

27.51

2.8

2.9

7.9

8.0

kpa

0.77

686

3439

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1908

11486

1.33

27.42

2.5

2.1

12.2

12.4

nmol/l

0.70

1652

10109

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

432

1902

1.79

27.36

1.2

1.3

259.0

282.9

pmol/l

0.61

336

1448

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

664

3292

1.60

27.04

1.1

3.8

9.2

u/ml

2.39

350

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

602

7394

0.63

26.78

1.6

1.5

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

540

2549

1.67

26.73

2.0

1.8

194.3

198.9

pmol/l

0.51

497

2394

(3017143) Hepatitis C virus Ab [Presence] in Serum

2165

13314

1.30

26.63

1.5

1.6

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

964

5204

1.47

26.51

1.6

—

(3024928) Oxygen saturation in Venous blood

701

3537

1.57

26.49

2.9

3.0

—

(4062490)

329

1343

1.93

26.41

1.4

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

330

1351

1.93

26.27

1.4

0.4

g/l

0.65

245

910

(3027135) IgG subclass 1 [Mass/volume] in Serum

330

1352

1.92

26.21

1.4

6.3

7.2

g/l

5.10

242

909

(3028192) IgG subclass 2 [Mass/volume] in Serum

330

1353

1.92

26.15

1.4

2.7

3.0

g/l

2.24

243

911

(3009214) Lutropin [Units/volume] in Serum or Plasma

537

2551

1.66

25.96

1.4

1.3

11.7

12.0

u/l

0.18

442

2037

(40762814) Titanium [Mass/volume] in Blood

115

294

3.07

25.78

2.2

2.3

4.4

3.7

ug/l

0.26

(3024980) IgG subclass 4 [Mass/volume] in Serum

473

2181

1.71

25.55

1.5

1.6

0.7

0.9

g/l

2.53

350

1615

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

200

689

2.28

25.01

1.1

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

544

2627

1.64

24.69

1.3

—

(3035637) Corticotropin [Mass/volume] in Plasma

403

1796

1.77

24.56

1.6

1.5

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

205

721

2.24

24.43

1.1

358.6

299.7

mg/l

1.50

178

621

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

694

3575

1.54

23.95

1.9

1.6

42.3

44.0

nmol/l

1.15

679

3448

(4024509)

362

1577

1.81

23.81

1.8

1.6

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

210

757

2.18

23.60

1.2

1.1

49.8

47.2

mg/l

0.23

176

625

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

3377

22170

1.22

23.50

5.3

4.6

33.0

32.5

1.59

2317

14565

(3039162) Centromere protein B Ab [Units/volume] in Serum

379

1681

1.78

23.49

1.3

1.2

31.5

60.8

u/ml

1.58

104

(3006184) Hemoglobin [Mass/volume] in Capillary blood

753

3968

1.50

23.37

2.3

2.2

127.3

129.1

g/l

1.09

539

2822

(3037556) Urate [Mass/volume] in Serum or Plasma

152

477

2.51

23.35

1.3

1.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

487

2320

1.66

23.34

1.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

275

1106

1.96

23.12

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

279

1130

1.94

22.99

1.4

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

206

750

2.16

22.61

2.5

2.3

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

760

4041

1.49

22.59

1.9

2.0

11.6

11.5

mg/l

0.10

695

3737

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

616

3134

1.55

22.51

1.2

1.1

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2225

14026

1.27

22.34

1.5

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

270

1093

1.95

22.30

1.7

2.0

—

(4027681)

161

531

2.38

22.27

1.2

1.3

—

(3020876) Protein [Mass/time] in 24 hour Urine

331

1440

1.81

21.91

1.6

2.0

0.6

0.9

g/24h

—

(3021901) Oxygen saturation in Capillary blood

627

3225

1.54

21.82

2.8

2.9

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

122

356

2.69

21.69

1.5

0.4

ug/l

0.04

222

(3045716) Anion gap in Serum or Plasma

196

712

2.17

21.66

3.3

2.3

8.9

9.3

mmol/l

0.66

126

535

(3038026) Centromere Ab [Units/volume] in Serum

286

1194

1.89

21.57

1.2

104.5

44.9

u/ml

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

280

1162

1.90

21.50

1.2

34.1

38.4

u/ml

0.14

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

279

1158

1.90

21.42

1.2

78.9

73.4

u/ml

0.08

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

2259

14339

1.26

21.35

3.8

3.9

1.2

mmol/l

1.26

1975

12445

(3016038) Potassium [Moles/volume] in Urine

263

1078

1.92

20.98

1.1

32.6

35.2

mmol/l

1.13

226

921

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1492

9015

1.31

20.79

2.9

2.8

0.3

e6/l

0.02

1465

8794

(3008295) Osmolality of Serum or Plasma

345

1549

1.76

20.58

1.3

1.4

276.0

278.3

mosm/kgh2o

0.85

244

1229

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

159

541

2.31

20.56

1.8

1.6

3.0

8.5

nmol/l

0.69

133

461

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

117

344

2.67

20.53

1.1

1.3

144.7

133.4

nmol/l

0.28

224

(3034891) Synovial lining cells/100 cells in Synovial fluid

194

720

2.12

20.35

1.5

3.9

3.4

0.15

167

(3003129) Base excess in Capillary blood by calculation

133

421

2.48

20.14

1.9

1.7

0.9

0.5

mmol/l

0.49

127

398

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

794

4360

1.44

20.03

2.3

2.4

124.5

111.2

ug/min

0.29

439

2548

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

218

855

2.01

19.76

1.9

2.0

16.2

15.6

nmol/l

0.47

205

798

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

262

1102

1.87

19.37

1.2

3.8

7.5

u/ml

0.59

(3035947) Staphylolysin Ab [Units/volume] in Serum

188

703

2.10

19.37

1.2

1.1

3.2

5.0

iu/ml

0.83

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

366

1705

1.69

19.18

3.7

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

258

1090

1.86

18.83

1.4

1.3

532.8

410.8

titre

0.21

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

317

1427

1.75

18.79

1.4

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

317

1427

1.75

18.79

1.4

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

317

1427

1.75

18.79

1.4

1.7

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

186

705

2.07

18.52

1.1

—

(40767503) Oxygen content in Capillary blood by calculation

683

3704

1.46

18.44

2.6

15.9

16.2

0.83

377

1914

(3003694) ABO and Rh group [Type] in Blood

5987

42042

1.15

18.27

1.4

1.3

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

336

1554

1.70

18.11

1.4

1.8

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

448

2236

1.58

17.89

1.3

1.4

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

584

3103

1.49

17.51

1.5

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

248

1060

1.84

17.50

1.4

1.3

95.5

77.0

titre

0.29

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

349

1650

1.67

17.36

1.4

1.7

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1361

8327

1.30

17.28

1.2

128.9

149.2

iu/ml

1.03

496

3029

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

623

3364

1.46

17.23

1.5

1.3

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

116

374

2.44

16.99

1.3

1.2

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

247

1073

1.81

16.57

1.2

1.1

—

51.1

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

270

1211

1.75

16.29

1.1

41.9

86.5

au/ml

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

129

447

2.27

16.12

1.3

1.4

15.3

15.8

pmol/l

0.36

100

385

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

206

855

1.89

15.97

1.8

1.7

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

276

1259

1.73

15.71

1.1

21.2

29.5

au/ml

—

(3030313) Adrenal Ab [Titer] in Serum

5.79

15.68

1.0

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

299

1402

1.68

15.40

1.6

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

636

3526

1.42

15.33

1.2

—

(3024869) Neuronal Ab [Presence] in Serum

264

2.62

14.99

1.1

—

(3010421) pH of Blood

778

4484

1.37

14.93

4.0

7.4

0.09

653

3832

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

354

1750

1.59

14.82

1.1

17.2

14.9

au/ml

—

(3028707) Methadone [Presence] in Urine by Screen method

198

833

1.87

14.77

3.2

2.3

—

(4015189)

129

465

2.18

14.71

2.9

2.1

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

539

2928

1.45

14.52

1.5

1.7

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

536

2910

1.45

14.49

1.4

1.6

—

(3042631) Mycobacterium sp identified in Specimen

477

2542

1.48

14.19

2.7

2.5

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

537

2938

1.44

13.95

2.7

3.3

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

402

2075

1.53

13.95

1.4

—

(1616796) Gas panel - Central venous blood

684

3905

1.38

13.94

3.5

3.7

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

183

767

1.88

13.85

1.3

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

294

1414

1.64

13.80

1.3

1.2

1.6

1.4

nmol/l

2.20

270

1269

(3005988) Vibrio sp identified in Specimen by Organism specific culture

401

2075

1.52

13.76

1.4

—

(3028271) Lactate [Moles/volume] in Capillary blood

504

2732

1.45

13.76

2.0

1.9

1.7

1.8

mmol/l

0.55

495

2659

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

276

2.50

13.75

1.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

414

2158

1.51

13.73

1.4

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

507

2754

1.45

13.69

1.3

30.4

34.6

u/l

0.39

454

2365

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

408

2122

1.51

13.68

1.6

1.5

—

(3000093) Morphology [Interpretation] in Blood Narrative

333

1655

1.58

13.67

1.1

—

(3011288) Drugs identified in Urine by Screen method

258

1207

1.68

13.48

3.5

2.5

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

181

763

1.86

13.47

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

399

2073

1.52

13.45

1.4

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

149

589

1.99

13.40

1.3

1.5

11.0

14.8

umol/l

0.60

104

430

(3016018) Differential panel - Cerebral spinal fluid

306

1501

1.60

13.29

1.5

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

654

3738

1.38

13.26

1.8

1.6

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

151

603

1.97

13.20

1.2

1.3

58.5

54.7

0.18

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

231

1056

1.72

13.14

1.1

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

152

610

1.96

13.11

1.6

13.8

8.6

ug/l

1.03

136

553

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

402

2108

1.50

12.99

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

402

2115

1.50

12.79

1.4

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

463

2506

1.46

12.78

1.1

1.2

—

(3051611) Lipemic interference index of Serum or Plasma

361

1861

1.53

12.65

3.6

—

(44813793)

189

825

1.80

12.62

1.1

—

(3002619) Bacteria identified in Specimen by Culture

290

2.38

12.43

1.4

1.3

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

281

2.40

12.38

1.1

0.6

0.7

umol/24h

1.01

141

(3034770) Mitochondria Ab [Titer] in Serum

690

4027

1.35

12.30

1.1

1.2

981.0

892.0

titre

—

127

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

229

1068

1.69

12.16

1.3

2.2

2.3

mmol/l

0.79

212

995

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

134

531

1.98

12.02

1.1

u/l

0.09

274

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

255

1228

1.63

11.98

1.4

1.3

33.0

37.3

u/l

1.20

208

985

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

193

865

1.75

11.83

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

193

865

1.75

11.83

1.4

—

(3007566) Smooth muscle Ab [Titer] in Serum

691

4060

1.34

11.81

1.1

1.2

108.2

132.7

titre

0.34

339

(3001019) Free T4 and TSH panel - Serum or Plasma

544

5809

0.73

11.62

1.7

—

(4094501)

762

4555

1.32

11.57

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

366

1931

1.49

11.54

3.8

—

(3027315) Oxygen [Partial pressure] in Blood

673

3955

1.34

11.50

3.9

4.1

8.4

8.5

kpa

0.68

658

3852

(3012501) Base excess in Blood by calculation

668

3931

1.34

11.31

3.9

4.1

2.5

2.6

mmol/l

0.91

486

2727

(3036489) Thrombin time

931

5735

1.28

11.30

1.9

21.3

21.9

1.84

813

5106

(3013290) Carbon dioxide [Partial pressure] in Blood

668

3933

1.34

11.28

3.9

4.1

5.0

kpa

1.34

653

3830

(3000330) Specific gravity of Urine by Test strip

1360

8756

1.23

11.24

4.0

3.5

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

402

2174

1.46

11.21

1.3

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

139

574

1.90

11.11

1.3

18.0

27.7

umol/l

3.98

133

540

(3017354) Segmented neutrophils/100 leukocytes in Blood

334

1744

1.51

11.09

3.6

3.5

59.8

58.8

0.29

219

1124

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

421

2308

1.44

10.93

2.0

2.3

32.7

0.02

415

2292

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

414

2263

1.44

10.92

1.5

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

3.81

10.76

1.1

1.0

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

148

631

1.84

10.74

1.3

1.2

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

222

1070

1.63

10.47

1.2

1.1

—

(3004451) EKG impression Narrative

185

852

1.71

10.37

1.3

1.2

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

764

4641

1.30

10.36

2.2

2.3

3.7

g/l

0.33

726

4430

(3020191) Ethanol [Moles/volume] in Serum or Plasma

221

1067

1.63

10.36

1.4

1.3

1.4

1.3

promille

0.83

159

829

(3005570) Glucose [Moles/volume] in Urine

324

1711

1.49

10.23

2.5

1.8

—

5.0

—

(4146454)

383

2092

1.44

10.18

2.8

2.7

—

(3023410) Appearance of Cerebral spinal fluid

265

1345

1.55

10.08

1.5

1.6

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

2876

19965

1.14

9.77

3.1

4.3

24.4

26.1

ug/l

0.06

2374

16413

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

127

533

1.87

9.73

1.3

1.4

28.7

30.0

umol/l

0.84

122

510

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

3.34

9.72

1.2

1.4

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

583

3444

1.33

9.69

1.7

39.6

7.4

iu/l

0.69

178

1173

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

103

403

2.01

9.68

1.3

1.2

20.0

27.2

0.36

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

194

924

1.65

9.63

1.3

0.9

1.7

u/ml

0.90

102

460

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

342

1862

1.44

9.30

1.2

54.8

61.9

u/l

1.82

223

1225

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

251

1283

1.54

9.29

1.6

1.7

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

249

2.27

9.25

1.7

8.5

8.9

mg/l

0.27

200

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

224

1120

1.57

9.15

1.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

755

4660

1.28

9.10

1.3

1.5

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

264

1372

1.51

9.07

1.3

1.2

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

156

714

1.72

9.01

1.1

9.1

8.8

iu/ml

0.08

174

(3004809) Band form neutrophils/100 leukocytes in Blood

496

2893

1.35

9.01

3.4

1.4

1.5

0.27

374

2248

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

747

0.36

8.97

15.4

11.2

901.4

2186.6

nmol/l

0.47

714

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

143

640

1.75

8.94

1.3

1.2

6.2

6.1

mmol/l

0.19

134

596

(3018851) Theophylline [Moles/volume] in Serum or Plasma

131

2.75

8.82

1.5

1.6

55.5

46.3

umol/l

0.79

131

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

225

1137

1.56

8.80

1.0

287.9

375.4

ng/l

1.66

137

834

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

392

1.96

8.71

1.9

2.3

1.3

1.0

ug/l

0.38

375

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

782

0.38

8.70

18.5

15.8

1527.4

3416.3

nmol/l

0.47

748

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

173

824

1.65

8.64

2.3

2.1

84.2

120.6

ug/min

0.47

197

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

225

1143

1.55

8.61

1.0

761.9

710.8

ng/l

0.83

137

808

(1001926) Buprenorphine [Presence] in Urine by Screen method

277

1471

1.48

8.60

2.6

1.8

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

120

516

1.83

8.59

1.8

2.4

20.9

367.5

ug/l

1.05

115

485

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

225

1144

1.55

8.57

1.0

35.0

44.9

ng/l

4.29

135

831

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1316

8681

1.20

8.54

1.3

1.4

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

305

2.08

8.49

1.1

—

(3051593) INR in Capillary blood by Coagulation assay

189

927

1.60

8.41

9.1

11.0

—

(3020618) Glucose [Moles/volume] in Synovial fluid

3.85

8.39

1.0

1.1

5.3

5.6

mmol/l

0.15

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

186

2.40

8.37

2.1

1.5

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

176

851

1.62

8.31

1.3

1.4

1.1

1.3

nmol/l

1.68

130

656

(3040151) Glucose [Moles/volume] in Capillary blood

352

1975

1.40

8.17

4.7

7.6

7.2

7.6

mmol/l

1.38

272

1617

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

129

577

1.76

8.13

1.2

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

364

1.96

8.12

1.2

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

878

5593

1.24

8.11

1.5

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

2712

18981

1.13

8.09

1.4

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

789

4970

1.25

8.07

1.5

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

126

563

1.76

7.98

1.4

1.7

173.2

161.8

0.71

114

526

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

176

862

1.60

7.91

3.5

3.8

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

432

2521

1.35

7.89

1.8

302.5

322.5

mu/l

0.40

395

2328

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

365

1.94

7.74

1.3

1.2

1.9

3.1

umol/l

7.03

334

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

195

986

1.55

7.67

1.1

1.2

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

203

1037

1.54

7.63

1.2

84.5

91.2

u/l

0.45

173

900

(3020491) Glucose [Moles/volume] in Blood

217

1126

1.51

7.60

1.8

1.9

7.3

7.2

mmol/l

0.21

161

744

(3006270) Folate [Moles/volume] in Blood

262

1413

1.46

7.59

1.2

334.7

353.1

nmol/l

0.77

223

1136

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

195

989

1.55

7.58

1.1

1.2

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

135

626

1.69

7.53

2.7

2.3

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

194

986

1.55

7.47

1.1

1.2

—

(4035726)

1884

16788

0.87

7.45

1.3

1.4

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

310

1731

1.41

7.44

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

182

2.33

7.44

1.4

1.7

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

103

443

1.82

7.43

1.1

1.0

—

(3023420) DNA double strand Ab [Units/volume] in Serum

261

1413

1.45

7.42

1.4

1.5

27.1

35.0

iu/ml

0.58

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

194

988

1.54

7.41

1.1

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

194

989

1.54

7.38

1.1

1.2

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

285

2.04

7.37

1.3

1.2

0.9

42.8

mg/l

0.99

212

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

197

1009

1.53

7.34

1.2

28.5

23.7

u/l

0.59

165

857

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

185

935

1.55

7.32

2.2

2.4

496.7

553.0

e6/l

0.56

164

786

(40759836) Histone Ab [Presence] in Serum by Immunoblot

193

985

1.54

7.31

1.1

1.2

—

(3000034) Microalbumin [Mass/volume] in Urine

277

1521

1.43

7.31

3.0

3.1

58.9

51.3

mg/l

0.12

204

1093

(3039443) Prostate specific Ag panel - Serum or Plasma

299

3249

0.72

7.30

1.7

—

(4211845)

175

876

1.57

7.23

4.7

3.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

156

761

1.61

7.18

1.2

1.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

177

890

1.56

7.17

2.3

2.5

0.2

e9/l

0.10

161

779

(3051339) Copper [Moles/volume] in Blood

3.62

7.16

1.1

17.7

17.4

umol/l

0.09

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

376

1.88

7.13

1.7

1.6

9.3

9.2

ug/l

0.12

376

(3032057) Clostridioides difficile [Presence] in Stool

344

1.92

7.06

1.6

1.8

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

6.72

6.93

1.1

1.5

—

(37021550) Renin [Units/volume] in Plasma --upright

325

1.93

6.90

1.3

1.2

75.1

72.4

mu/l

0.05

239

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

4.02

6.86

1.1

1.0

0.1

u/ml

—

(3052592) Norovirus Ag [Presence] in Stool

338

1.90

6.78

1.2

1.3

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

366

1.87

6.77

1.1

95.1

81.1

2.63

183

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

378

1.85

6.73

1.1

89.0

82.4

1.32

191

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

5141

37583

1.09

6.60

3.1

0.7

0.8

ug/l

7.00

3672

25791

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

381

1.83

6.57

1.1

113.6

102.1

2.37

352

(40761536) Microorganisms panel - Urine sediment

1970

13707

1.14

6.46

5.0

3.9

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

412

1.79

6.44

1.1

1.3

0.3

g/l

0.23

327

(3035320) C reactive protein [Mass/volume] in Body fluid

209

1118

1.47

6.39

3.1

2.3

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

3.14

6.31

2.0

1.6

1.7

1.5

mg/l

0.26

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

381

1.81

6.29

1.2

271.0

289.3

pmol/l

0.14

280

(3006462) Nitrate [Presence] in Urine

160

812

1.55

6.29

4.9

3.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

121

575

1.65

6.24

1.2

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

315

1.89

6.22

1.3

1.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

642

4081

1.24

6.16

1.6

1.5

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

390

1.79

6.13

1.1

1.3

111.1

113.8

0.42

344

(3047189) Immunofixation for 24 hour Urine

154

782

1.55

6.06

1.5

1.8

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

308

1.88

6.00

1.2

1.3

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

392

2356

1.31

5.96

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

156

800

1.53

5.88

1.6

1.7

—

(3028717) Thiamine [Mass/volume] in Blood

123

2.42

5.79

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

134

669

1.57

5.70

1.0

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

204

1113

1.44

5.69

1.8

1170.8

1986.1

u/l

0.43

393

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

400

1.75

5.66

1.6

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

354

1.80

5.66

1.1

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

114

549

1.63

5.63

1.2

1.1

1309.2

573.2

ng/l

0.50

145

(3028433) Virus identified in Specimen by Culture

110

525

1.64

5.63

1.1

1.2

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

170

2.17

5.59

1.3

1.2

86.9

119.2

ug/l

0.93

109

(40768800) Prostate Pathology biopsy report

458

4510

0.79

5.58

1.2

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

3.55

5.56

1.1

1.0

0.1

u/ml

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

125

618

1.59

5.56

1.1

2.8

6.4

u/ml

1.61

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

162

850

1.50

5.52

2.8

3.4

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.71

5.51

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

352

1.78

5.48

1.1

—

(3002256) Pathology report gross observation

3161

22792

1.10

5.45

1.3

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

124

615

1.58

5.45

1.5

1.4

—

(4198724)

280

1.88

5.41

1.6

1.4

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

387

2356

1.29

5.39

1.1

—

(21494434) Karyotype in Bone marrow

270

1562

1.36

5.38

1.1

1.2

—

(3006576) Bicarbonate [Moles/volume] in Blood

125

624

1.57

5.35

5.3

6.4

25.3

25.0

mmol/l

0.41

114

557

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

2.71

5.34

1.4

1.3

19.3

13.5

0.45

(3047007) Chlamydophila sp Ab [Presence] in Serum

289

1692

1.34

5.33

1.3

1.2

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

327

1.80

5.31

1.1

—

(3001186) Copper [Moles/volume] in Serum or Plasma

299

1.84

5.29

1.1

1.2

16.4

17.1

umol/l

0.47

264

(3011412) CD3 cells [#/volume] in Blood

247

1414

1.37

5.26

2.1

2.3

1.2

1.1

e9/l

0.84

141

865

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

110

2.42

5.22

1.0

—

(3000012) Reticulocyte production index

185

1009

1.44

5.21

1.4

1.6

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

277

1618

1.35

5.20

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

142

735

1.52

5.19

1.2

1.1

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

251

1.91

5.18

1.6

126.2

111.4

ug/l

0.47

202

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

150

787

1.50

5.15

1.5

2.0

100.6

95.2

0.94

136

750

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

191

1052

1.43

5.11

2.4

2.5

690.9

698.9

e6/l

0.02

437

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

2.51

5.10

1.3

1.2

0.2

nmol/l

0.28

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

209

1.99

5.08

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

172

2.10

5.07

1.7

2.1

15.8

19.2

umol/l

1.39

172

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

131

670

1.53

5.07

1.1

—

(3017569) Oxygen content in Arterial blood

153

809

1.48

5.06

2.1

2.2

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

199

2.01

5.04

1.3

1.2

47.6

50.8

0.16

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

146

767

1.49

4.99

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

353

1.73

4.91

1.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

115

577

1.56

4.86

3.1

2.9

29.8

29.1

umol/l

0.29

439

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

224

1.93

4.83

1.0

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

349

1.73

4.83

1.1

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3.79

4.82

1.0

—

(3036603) Volume of Urine

204

1155

1.39

4.70

1.7

1.6

2122.5

1925.6

0.96

304

(4281824)

189

2047

0.72

4.70

1.1

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

100

490

1.60

4.68

1.3

1.5

2.3

2.0

umol/l

2.03

455

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

653

4285

1.20

4.67

2.3

2.2

206.7

201.7

0.67

611

4049

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

2.42

4.65

1.4

36.0

44.7

0.44

(3046904) Somatotropin [Units/volume] in Serum or Plasma

5.23

4.59

1.4

3.3

1.4

2.1

mu/l

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

3.10

4.59

1.0

1.2

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

396

2472

1.26

4.58

1.8

1.9

39.3

23.9

ug/l

1.20

385

2421

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

108

2.32

4.53

1.0

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

417

1.64

4.47

6.0

64.2

70.7

1.15

342

(1617658) Protocol used for examination of sentinel lymph nodes

119

1385

0.67

4.46

1.0

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

595

3890

1.20

4.45

2.5

3.4

422.3

881.3

u/ml

1.33

526

3532

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

114

2.27

4.44

1.2

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

277

1660

1.31

4.43

1.2

7.8

7.7

mmol/l

0.20

199

1188

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

395

1.65

4.39

1.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

105

2.31

4.37

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

154

843

1.43

4.33

1.9

2.0

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

306

1867

1.29

4.29

1.1

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

106

2.29

4.28

1.1

—

(3016879) Cocaine [Presence] in Urine

303

1848

1.29

4.27

2.7

1.7

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

134

717

1.47

4.25

1.1

1.2

1.1

ratio

0.52

272

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

174

1.98

4.25

2.0

2.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

192

1099

1.37

4.19

1.6

1.5

6.4

5.9

u/l

0.17

504

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

699

4663

1.18

4.19

2.1

2.0

92.2

89.0

3.36

654

4347

(3006245) CD3-CD19+ cells/100 cells in Blood

451

1.58

4.12

2.0

1.9

9.5

11.7

0.79

409

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

246

1467

1.32

4.11

1.1

1.2

2.1

iu/ml

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

232

1.83

4.10

1.1

1.3

727.3

222.6

u/l

0.34

165

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

707

0.56

4.09

1.3

1.4

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

153

847

1.42

4.08

3.0

2.8

41.0

37.1

0.94

279

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

188

1.92

4.06

1.2

—

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

2.58

4.05

1.3

1.2

1.1

1.4

0.14

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

119

629

1.48

4.04

1.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

343

0.39

3.96

1.4

1.5

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

179

1.93

3.95

2.0

2.1

—

(3022689) Creatine [Moles/volume] in Urine

482

1.55

3.91

1.3

1.5

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

306

1.69

3.90

1.7

1.3

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

534

3505

1.20

3.88

1.3

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

369

2334

1.24

3.88

1.0

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

243

1.78

3.84

1.0

1.2

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

460

1.55

3.82

2.5

3.1

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

492

3214

1.20

3.78

5.4

5.7

2813.8

1256.2

iu/ml

0.32

531

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

311

1936

1.26

3.77

1.2

4.9

3.6

u/ml

0.64

127

883

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

194

1.86

3.73

1.1

1.3

9.0

219505.7

nmol/l

0.94

159

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

234

1.78

3.72

2.2

2.4

270.3

185.8

au/ml

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.50

3.68

1.1

1.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

131

720

1.43

3.68

1.6

2.0

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

132

727

1.42

3.66

1.6

2.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

131

721

1.43

3.65

1.6

2.0

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

459

1.54

3.65

2.1

1.8

30.0

30.3

0.05

429

(3028300) Cannabinoids [Presence] in Urine

318

1995

1.25

3.62

2.7

1.7

—

(3000764) Benzodiazepines [Presence] in Urine

315

1975

1.25

3.61

2.6

1.7

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

423

1.56

3.61

1.4

1.8

183.5

186.2

0.11

400

(40768795) Lymph node Pathology biopsy report

181

1885

0.75

3.58

1.1

1.2

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

357

2273

1.23

3.57

1.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

384

2464

1.22

3.56

1.5

2201.5

2411.2

e6/l

0.20

295

1783

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

456

1.53

3.55

2.0

2.1

61.8

38.0

u/l

0.41

412

(43055514) Macroprolactin [Presence] in Serum or Plasma

153

1.95

3.55

1.5

1.4

—

(3027008) Opiates [Presence] in Urine

316

1987

1.25

3.54

2.6

1.7

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

256

1.72

3.51

2.7

3.0

6.9

7.9

mg/l

0.49

204

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

324

0.41

3.51

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

324

0.41

3.51

1.4

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

327

2067

1.24

3.50

1.1

1.6

1.5

g/l

0.30

288

1867

(3042517) Benzodiazepines panel - Urine

2.78

3.46

2.4

2.7

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

478

1.51

3.45

1.2

1.1

1661.6

1562.4

miu/ml

0.33

478

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

2.57

3.37

1.0

152.9

203.4

pmol/l

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

306

2957

0.81

3.33

3.4

3.5

33.6

41.9

u/ml

0.80

301

2839

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

158

914

1.36

3.32

1.6

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

158

914

1.36

3.32

1.6

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

158

914

1.36

3.32

1.6

1.9

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

273

1.67

3.30

1.1

1.4

175.7

245.6

titre

—

(3050794) Legionella sp Ab [Presence] in Serum

130

1.99

3.29

1.1

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

325

0.43

3.28

1.3

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

325

0.43

3.28

1.3

1.4

—

(3019174) dRVVT (LA screen)

109

2.09

3.27

1.1

1.2

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

316

2007

1.24

3.27

2.6

3.5

5.4

8.9

nmol/l

0.69

300

1964

(3018133) Calcium [Moles/volume] in Urine

175

1.84

3.25

1.3

1.5

2.6

2.8

mmol/l

0.17

154

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

157

912

1.35

3.23

1.6

1.9

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.15

3.15

1.0

1.1

—

(3020650) Glucose [Presence] in Urine

364

1.55

3.10

1.5

1.4

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

112

2.03

3.07

5.0

4.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

285

1806

1.24

3.04

1.5

1.6

—

(3043410) Blood group antigens tested for on Red Blood Cells

468

1.47

3.00

1.6

2.0

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

2.13

2.99

1.5

1.6

1.0

0.7

umol/l

2.48

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

3.56

2.98

1.1

1.0

—

(3003434) Protein [Mass/volume] in Pleural fluid

421

2781

1.19

2.96

1.5

1.4

31.9

32.7

g/l

0.67

375

2491

(3028308) Erythrocytes [#/volume] in Pleural fluid

346

2245

1.21

2.95

1.5

83868.0

57202.6

e6/l

0.62

211

1335

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

541

1.44

2.95

1.2

1.1

27.7

5.2

u/ml

0.72

(3007916) DNA double strand Ab [Titer] in Serum

170

1.80

2.93

1.3

1.1

—

210.5

—

(3000060) B lymphocytes [#/volume] in Blood

301

1.59

2.93

2.1

1.8

338.1

2402.4

e6/l

1.28

147

(3041918) Cholesterol [Moles/volume] in Pleural fluid

351

1.54

2.91

1.1

1.2

1.5

1.7

mmol/l

0.57

214

(3023383) Lactate [Moles/volume] in Pleural fluid

108

602

1.41

2.89

1.3

3.0

3.4

mmol/l

1.14

558

(42529582) MDA5 Ab [Presence] in Serum by Line blot

365

1.53

2.86

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

365

1.53

2.86

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

365

1.53

2.86

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

365

1.53

2.86

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

284

0.44

2.84

1.4

1.5

—

(3000285) Sodium [Moles/volume] in Blood

225

1.67

2.82

1.2

—

(3023511) Choriogonadotropin [Units/volume] in Urine

411

1.49

2.81

1.2

—

(3027944) Amphetamines [Presence] in Urine

302

1944

1.22

2.81

2.2

1.6

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

144

1.85

2.80

1.1

1.8

umol/24h

0.13

144

(3006922) Hepatitis E virus Ab [Presence] in Serum

167

1003

1.31

2.79

1.0

1.1

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

262

1.62

2.79

1.1

1.2

96.0

82.0

1.01

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

299

1925

1.22

2.78

1.5

1.6

—

(3029075) Extractable nuclear Ab panel - Serum

412

1.48

2.78

1.0

1.1

—

(3048879) Bone marrow aspiration report

548

1.42

2.77

1.3

1.8

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

225

1405

1.26

2.77

1.4

12.9

13.0

u/l

0.13

212

1356

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

2.09

2.76

1.0

1.1

52.3

52.6

u/l

0.01

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

536

1.42

2.75

1.7

1.6

151717.9

13632.6

u/ml

0.75

(4306422)

295

1903

1.22

2.70

1.2

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

176

1070

1.29

2.70

1.1

292.1

569.3

mg/l

0.50

152

955

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

146

1.83

2.70

1.9

2.3

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

434

3972

0.85

2.69

4.4

3.2

25.1

28.3

mg/l

1.17

251

2557

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

3.08

2.68

2.3

1.1

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

120

692

1.36

2.66

2.8

4.8

78.9

1584.0

mg/l

1.57

489

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

298

1930

1.21

2.63

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

275

0.46

2.63

1.4

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

156

937

1.31

2.63

1.0

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

437

1.45

2.62

8.2

8.5

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

373

1.49

2.62

1.1

—

(1175426) CD3 cells/100 lymphocytes in Blood

179

1096

1.28

2.61

1.8

1.9

72.5

71.3

0.50

171

1051

(3005033) Fetal Nuchal fold Thickness US

274

0.46

2.61

1.4

—

(40757373) Influenza virus identified in Isolate

324

1.52

2.57

1.9

1.6

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

2.14

2.57

2.1

1.9

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

176

1078

1.28

2.57

1.8

1.9

15.2

15.0

0.06

415

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

307

2000

1.21

2.57

1.2

5.1

4.0

u/ml

0.34

722

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

156

941

1.30

2.56

1.0

1.1

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

2.28

2.54

1.4

1.5

0.8

0.2

u/l

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

168

1025

1.29

2.53

1.8

1.9

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.68

2.53

1.1

1.5

—

(3011897) Casein IgE Ab [Units/volume] in Serum

110

1.92

2.52

1.1

0.0

2.4

u/ml

—

(3019977) pH of Arterial blood

162

985

1.29

2.51

3.0

2.4

7.4

0.28

368

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

144

1.80

2.51

1.2

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

264

1.57

2.50

1.1

1.2

79.4

73.6

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

234

1.61

2.47

1.5

1.7

61.9

52.8

pmol/l

0.25

194

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

2.19

2.47

1.5

0.3

1.8

mg/l

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

372

1.48

2.46

8.3

8.4

—

(3050129) First trimester maternal screen panel - Serum or Plasma

381

0.55

2.46

1.4

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

213

1343

1.24

2.46

2.1

1.8

4.3

4.0

mg/l

0.45

202

1272

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

246

1577

1.22

2.44

1.1

1.8

3.8

u/ml

3.78

660

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

490

1.41

2.43

1.1

1.2

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

155

942

1.29

2.43

1.2

1.1

25.3

26.7

u/l

0.12

119

714

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

346

2298

1.18

2.37

1.7

1.6

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

113

1.87

2.35

1.3

1.5

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

119

702

1.33

2.32

1.4

1.3

—

(3035880) pH of Pleural fluid

177

1101

1.26

2.32

1.2

1.3

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

911

0.72

2.32

1.1

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

333

1.48

2.30

2.4

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

154

943

1.28

2.29

1.2

1.1

81.8

89.1

u/l

0.43

120

741

(3020393) Adenovirus Ag [Presence] in Stool

137

1.77

2.29

1.1

1.0

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

517

1.38

2.26

1.0

1.1

104.6

97.9

1.32

410

(3044009) aPTT.lupus sensitive (LA screen)

109

1.87

2.26

1.2

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

538

4780

0.88

2.26

1.6

1.7

3.3

3.5

mg/l

0.24

415

3423

(3001729) Color of Synovial fluid

132

1.78

2.25

1.4

1.7

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

135

1361

0.78

2.25

1.1

1.2

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

104

1.88

2.23

1.1

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

160

989

1.27

2.22

1.9

2.3

2.5

u/field

0.18

101

695

(3010503) CD19 cells [#/volume] in Blood

158

977

1.27

2.19

2.1

2.5

0.2

0.5

e9/l

1.17

151

948

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

465

0.62

2.19

2.1

2.6

109.8

154.3

nmol/l

2.30

410

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

230

1.57

2.17

1.3

1.4

74.3

73.2

0.10

192

(3024932) HLA-DR beta [Type]

549

0.66

2.16

1.1

—

(3051651) Icteric interference index of Serum or Plasma

173

1084

1.25

2.16

3.9

4.1

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

413

2807

1.16

2.15

1.2

1.4

21.6

21.0

u/ml

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

219

1409

1.22

2.14

1.4

1.5

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

123

1.78

2.13

1.1

1.2

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

3.07

2.13

1.0

1.8

2.4

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

272

0.52

2.10

1.3

1.4

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

112

1.82

2.10

1.4

1.8

0.6

0.9

0.47

(4212803)

165

1.66

2.09

1.1

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

415

2828

1.15

2.09

1.3

1.4

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

323

2161

1.17

2.07

1.3

1.2

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.98

2.07

9.5

8.5

—

(37019676) Renin [Units/volume] in Plasma --supine

2.61

2.06

1.0

57.7

55.8

mu/l

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

113

1.80

2.05

1.0

1.1

11.0

11.6

u/l

0.06

113

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

184

1170

1.23

2.03

1.1

1.2

—

(36303858) Crystals [Presence] in Urine

3.13

1.98

1.1

—

(40768793) Breast Pathology biopsy report

415

3711

0.87

1.97

1.3

—

(3036782) Glucose [Moles/volume] in Pleural fluid

276

1833

1.18

1.96

1.3

6.7

6.3

mmol/l

1.18

261

1695

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

280

1862

1.18

1.95

1.1

125.0

116.5

3.49

249

1668

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

487

3374

1.13

1.95

1.8

1.5

0.9

0.8

nmol/l

0.91

388

2788

(3027874) Urate [Moles/volume] in Urine

2.24

1.95

1.1

1.4

1.6

mmol/l

—

(3024471) HLA-A [Type]

563

0.68

1.94

1.0

—

(3045788) Cell count panel - Pleural fluid

284

1894

1.18

1.92

1.5

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.09

1.90

1.1

1.2

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

232

1.52

1.90

2.4

3.0

0.4

0.5

u/field

0.53

232

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

126

774

1.28

1.90

2.8

5.5

62.2

5843.2

u/ml

—

137

(3003721) Smooth muscle Ab [Units/volume] in Serum

2.02

1.86

1.1

—

2.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

693

0.72

1.83

1.4

1.5

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

106

1.77

1.82

1.0

5.4

4.2

u/ml

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

2.85

1.80

1.0

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

229

1.51

1.80

2.3

2.0

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

179

1.58

1.79

1.8

1.4

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

326

1.42

1.79

1.2

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

554

1.32

1.78

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

108

0.36

1.78

1.4

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

294

1.44

1.77

6.4

7.3

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.83

1.76

1.0

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

162

1.60

1.74

1.1

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

1.96

1.73

1.5

1.0

3.0

mg/l

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

1.96

1.73

1.5

1.6

2.4

mg/l

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

1.96

1.73

1.5

5.3

3.0

mg/l

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

1.96

1.73

1.5

0.6

2.2

mg/l

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

1.96

1.73

1.5

0.7

1.1

mg/l

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

1.96

1.73

1.5

0.3

1.4

mg/l

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

1.96

1.73

1.5

0.8

2.1

mg/l

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

1.96

1.73

1.5

1.1

2.5

mg/l

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.96

1.73

1.0

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

1.96

1.73

1.5

1.2

2.1

mg/l

—

(3012565) Volume of 24 hour Urine

132

827

1.25

1.72

2.0

2.3

2033.3

1949.4

0.38

116

715

(3003888) Timothy IgE Ab [Units/volume] in Serum

235

1561

1.18

1.71

1.1

2.0

3.3

u/ml

1.44

112

674

(3002621) Streptococcal DNAse B [Units/volume] in Serum

109

1.73

1.68

1.1

1.0

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

100

608

1.29

1.67

1.8

2.4

58.0

55.9

umol/l

0.25

486

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1.82

1.67

1.0

1.1

12.8

14.5

nmol/l

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

492

1.32

1.66

1.5

1.4

22.9

21.7

0.16

412

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

189

1.53

1.66

1.1

1.3

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

104

1.73

1.64

1.0

1.1

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

2.61

1.63

1.0

1.1

2228.8

2276.3

titre

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

190

1.53

1.63

1.1

1.3

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

190

1.53

1.63

1.1

1.3

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

225

1500

1.18

1.59

1.3

12.1

13.5

u/l

0.83

204

1391

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

381

1.36

1.59

1.1

—

(3042733) HLA Ab [Presence] in Serum

530

0.71

1.58

4.5

5.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

230

1.47

1.58

1.2

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

360

2488

1.14

1.57

2.4

2.7

523.4

3298.6

u/ml

1.01

159

(4268621)

196

1294

1.19

1.56

2.2

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

3.56

1.56

1.0

1.1

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

252

1700

1.16

1.55

1.4

2.1

1.3

5.6

titre

—

(3036071) Salmonella sp Ab [Titer] in Serum

336

1.38

1.55

1.1

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.79

1.53

1.2

1.0

—

(3051101) Glucose [Moles/volume] in Cord blood

405

0.68

1.51

4.8

6.2

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

298

1.39

1.50

1.2

1.1

2.6

10.3

pmol/l

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

275

1873

1.15

1.50

1.4

1.3

422.7

483.2

u/l

0.30

260

1783

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

137

878

1.22

1.50

1.4

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

137

879

1.22

1.48

1.4

1.5

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

386

1.34

1.48

1.9

2.3

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

156

1015

1.21

1.47

1.4

14.5

13.3

umol/l

0.99

148

957

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

523

1.29

1.47

3.6

2.4

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

523

1.29

1.47

3.6

2.4

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

465

3279

1.11

1.47

1.2

—

(3046861) Legionella sp Ag [Presence] in Urine

102

1.69

1.46

1.0

1.1

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

221

1.45

1.46

3.0

3.1

41.7

40.0

umol/l

0.18

189

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

187

1238

1.18

1.46

1.0

1.1

—

(3012441) Differential panel - Pleural fluid

313

2156

1.14

1.46

1.5

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

507

3594

1.11

1.45

1.3

36.3

37.2

iu/l

0.26

430

3086

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.75

1.43

1.1

1.2

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

1.75

1.43

1.5

1.7

24.2

23.9

mmol/l

0.06

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

238

0.59

1.41

3.0

5.1

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

2.77

1.41

1.3

1.0

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

337

2342

1.13

1.39

1.1

32022.7

458.9

iu/ml

0.49

433

(3034092) Cytoplasmic Ig cells/100 cells in Blood

179

1.49

1.38

15.3

9.9

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

130

0.48

1.37

1.0

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.87

1.37

1.0

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

453

1.30

1.37

1.7

1.5

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

108

684

1.24

1.35

2.0

2.9

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

164

1083

1.19

1.35

1.6

74.1

72.0

umol/l

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

279

1.38

1.33

1.1

1.3

—

(3015183) Erythrocyte sedimentation rate

539

1.27

1.32

1.2

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

553

1.26

1.32

1.2

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1067

7849

1.07

1.30

3.0

4.1

43.1

66.4

u/ml

2.86

1017

7571

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

191

1283

1.17

1.29

4.2

5.2

190.9

86.5

u/ml

0.58

387

(3008401) Mugwort IgE Ab [Units/volume] in Serum

223

1519

1.15

1.26

1.1

0.8

1.1

u/ml

0.46

566

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

209

1.43

1.26

1.2

1.1

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

2.80

1.25

1.2

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

229

1.40

1.25

1.2

—

(3041184) Isoniazid [Presence] in Urine

2.47

1.25

2.5

2.8

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

384

1.31

1.25

1.2

1.3

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

1.70

1.25

1.1

1.2

1432.4

3789.4

ng/l

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

164

1.48

1.25

1.1

1.9

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

243

1.39

1.23

1.1

1.0

0.3

1.1

u/ml

1.11

109

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

2.00

1.23

1.5

1.4

443.1

488.1

nmol/l

0.11

(4133840)

386

1.30

1.21

1.3

1.2

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

172

1.46

1.20

1.1

—

(3025315) Body weight

147

1.49

1.18

4.6

4.7

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

183

1237

1.16

1.17

1.1

1.2

77.0

162.0

titre

3.54

226

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

151

1005

1.18

1.17

1.4

1.5

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

151

1006

1.18

1.16

1.4

1.5

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

2.09

1.16

1.3

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

253

1755

1.13

1.1

0.7

1.3

u/ml

1.41

632

(3000919) Neutrophils/100 leukocytes in Pleural fluid

545

1.24

1.12

1.3

1.4

23.7

19.3

0.73

485

(3017937) Magnesium [Moles/time] in 24 hour Urine

2.02

1.12

1.1

1.3

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

183

0.60

1.10

1.4

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

358

2541

1.11

1.08

1.3

1.4

110.2

117.5

u/ml

0.72

568

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

1.62

1.08

1.2

1.3

41.9

44.6

mg/l

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.79

1.07

15.5

14.4

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

119

1.51

1.05

1.2

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

292

1.32

1.04

1.1

1.2

—

(3009871) Measles virus Ab [Titer] in Serum

437

0.75

1.04

1.6

—

(3006567) Chloride [Moles/time] in 24 hour Urine

2.11

1.04

1.1

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

656

0.80

1.04

14.3

12.0

0.6

mmol/l

0.86

591

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

932

6892

1.06

1.02

2.7

3.6

726.7

1349.1

u/ml

1.02

789

5929

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

186

1.39

1.00

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

162

1102

1.15

1.00

1.4

0.3

0.2

nmol/l

0.36

106

773

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.86

0.99

1.0

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

295

1.30

0.99

1.2

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.61

0.95

1.1

1.5

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

529

1.22

0.94

1.5

1.4

4901446.2

1239703.2

iu/ml

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.66

0.93

1.1

1.6

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

204

1418

1.13

0.93

1.2

1.1

96.6

95.9

0.12

187

1312

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

169

1.39

0.93

1.2

1.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

595

1.20

0.92

1.4

1.3

68.6

302.2

ug/l

2.33

324

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

169

1162

1.14

0.92

1.4

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

192

0.65

0.91

1.3

1.1

86.1

65.4

u/ml

0.40

182

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

286

1.29

0.90

3.1

3.2

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

133

0.59

0.88

1.0

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

159

1.38

0.84

1.5

1.3

11.3

9.5

mmol/l

1.55

(3032868) Hemoglobin electrophoresis panel in Blood

100

1.49

0.84

1.6

—

(3036525) Urea [Moles/time] in 24 hour Urine

111

0.56

0.84

2.9

3.3

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

172

1195

1.13

0.82

1.0

1.9

2.8

u/ml

0.72

430

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

330

2374

1.09

0.82

1.1

1.3

276.6

287.2

u/ml

0.31

198

1509

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.59

0.81

1.2

1.1

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

101

1.47

0.81

8.2

4.6

—

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

1.65

0.79

1.2

1.4

186.9

108.4

ug/l

—

(3034426) Prothrombin time (PT)

433

1.21

0.79

1.2

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

278

1.27

0.79

1.2

1.1

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

0.57

0.79

6.0

6.9

—

(3025130) Human papilloma virus identified in Specimen

162

1428

0.89

0.78

1.5

1.7

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

588

4334

1.06

0.78

2.7

2.9

1.7

1.6

mg/l

1.74

525

3937

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

203

1432

1.11

0.77

1.2

1.1

—

(44806420)

613

0.83

0.76

2.2

2.4

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

129

1.40

0.76

1.1

1.2

—

(3005011) Chlamydia sp Ab [Titer] in Serum

163

1.35

0.75

1.7

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

105

0.60

0.74

1.1

1.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

262

0.75

0.71

1.8

1.6

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.54

0.68

1.0

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

238

1708

1.09

0.67

1.3

1.2

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

695

0.86

0.66

1.4

1.5

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

669

1.15

0.65

1.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

272

1.24

0.65

1.1

1.2

—

(3034614) HLA Ag [Interpretation]

1.78

0.65

1.0

1.3

—

(3022475) Manganese [Moles/volume] in Blood

100

0.63

0.65

1.0

1.3

—

(40762365) Oxygen content in Arterial blood by calculation

323

1.21

0.63

2.3

3.3

14.8

14.6

ml/dl

0.20

303

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

105

724

1.14

0.62

1.3

1.4

63.0

64.0

0.10

588

(46235168) Fasting glucose [Moles/volume] in Blood

184

0.72

0.62

1.6

2.7

7.0

7.4

mmol/l

—

101

(3010726) Horse dander IgE Ab [Units/volume] in Serum

192

1371

1.10

0.62

1.1

1.0

0.3

1.4

u/ml

3.43

290

(3009992) Blasts/100 cells in Bone marrow

0.00

0.61

0.0

1.7

—

14.3

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.61

0.0

1.0

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

108

0.65

0.61

1.2

1.1

—

(3018291) Platelet Ab [Presence] in Serum

1.74

0.58

1.2

1.1

—

(3001556) Androgen free Index in Serum or Plasma

1.74

0.58

1.2

1.5

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

138

973

1.11

0.58

1.0

0.1

0.7

u/ml

1.61

207

(3026250) Tacrolimus [Mass/volume] in Blood

694

0.87

0.57

36.0

33.4

7.2

ug/l

0.04

623

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.68

0.57

1.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.53

0.55

1.0

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

460

1.16

0.54

1.2

—

(40768441) Liver Pathology biopsy report

142

1226

0.91

0.54

1.2

1.3

—

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

1.47

0.53

1.3

1.5

1.8

2.4

0.45

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

118

1.33

0.53

1.1

1.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

675

1.13

0.52

1.2

1.1

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.52

0.52

1.0

—

(3049242) von Willebrand panel - Platelet poor plasma

1.41

0.51

2.2

1.5

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

346

2554

1.06

0.51

1.1

1.2

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

157

1125

1.09

0.50

1.2

12.4

12.2

mmol/l

0.10

361

(40768446) Kidney Pathology biopsy report

627

0.87

0.50

1.4

1.7

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.36

0.50

1.3

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

225

1.22

0.49

1.2

—

(3010375) cycloSPORINE [Mass/volume] in Blood

101

708

1.12

0.49

35.4

29.2

111.1

113.8

ug/l

0.20

593

(3018834) Bilirubin.total [Presence] in Urine by Test strip

0.64

0.49

3.0

3.9

—

0.0

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

276

1.19

0.48

1.1

1.3

1.0

1.3

mmol/l

0.21

176

(3008536) Aspergillus sp Ab [Presence] in Serum

334

1.17

0.48

1.4

2.3

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

378

1.16

0.48

2.5

7.7

7.6

mmol/l

0.07

229

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.35

0.47

1.0

1.1

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

191

1.23

0.47

4.1

3.0

1.9

1.1

mg/l

0.98

138

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

0.67

0.46

1.9

2.2

19.0

21.1

mg/l

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

249

1.20

0.46

1.3

1.2

127.2

136.3

ng/l

0.04

167

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

278

1.18

0.45

1.1

1.0

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

1.35

0.45

1.4

1.6

1.3

1.4

umol/l

0.75

(1002224) Polysomnography panel

716

5408

1.04

0.44

1.1

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

551

0.88

0.42

1.0

0.4

0.9

u/ml

0.69

122

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.00

0.41

0.0

1.1

—

(3052912) Proteinase 3 IgG Ab [Units/volume] in Serum

1.51

0.41

1.0

—

49.0

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

1.51

0.41

6.0

5.8

0.6

0.2

mmol/l

—

(3028468) Fragments [Presence] in Blood by Light microscopy

0.00

0.41

0.0

1.2

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

312

1.16

0.39

1.4

10.9

12.1

0.11

152

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

237

1750

1.06

0.39

2.6

3.8

26.7

63.8

u/ml

8.08

229

1728

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

510

4152

0.96

0.37

1.3

—

(40765089) Chromosome analysis panel - Blood by G-banded

107

0.73

0.37

1.0

—

(44806071)

161

1.22

0.37

1.0

1.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

0.69

0.37

1.9

2.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

120

866

1.09

0.37

1.1

1.2

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

205

1.19

0.36

1.2

1.1

22.6

18.3

u/l

0.37

137

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

278

1.16

0.36

1.6

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

152

1277

0.93

0.36

1.2

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

1.42

0.35

1.0

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

344

0.87

0.35

1.5

1.7

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

467

0.89

0.34

1.1

1.0

0.4

0.3

u/ml

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

560

4241

1.04

0.34

1.3

—

(3014891) Appearance of Pleural fluid

295

1.14

0.33

1.3

1.6

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.67

0.33

1.5

1.4

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.67

0.33

1.0

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.67

0.33

1.0

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

1.31

0.33

5.8

9.4

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

171

1.19

0.33

1.1

1.0

—

2.7

—

(3038515) Glucose [Moles/volume] in Venous blood

497

4032

0.97

0.32

4.3

3.2

7.5

7.7

mmol/l

1.01

486

3972

(21494815) CD4 cells/100 lymphocytes in Specimen

177

1308

1.06

0.31

1.8

2.1

39.8

38.6

0.14

155

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.34

0.31

1.0

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

129

0.79

0.30

1.9

2.1

0.4

1.1

mmol/l

—

(3016750) Collection duration of Urine

150

1106

1.06

0.29

2.2

2.1

494.5

499.2

min

0.28

105

806

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

494

0.90

0.29

1.1

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

621

1.09

0.29

1.3

1.4

3.7

2.4

0.75

517

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

1.31

0.28

1.1

1.0

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

211

1574

1.05

0.28

2.0

2.5

2.4

u/field

0.04

612

(3026692) Albumin [Mass/volume] in Peritoneal fluid

484

0.91

0.28

1.2

1.3

11.6

13.4

g/l

0.90

386

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

1.20

0.25

1.2

1.3

1.1

1.3

—

(1761482) Bacteria [#/volume] in Urine by Culture

628

5043

0.98

0.24

5.2

4.0

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

167

0.84

0.24

1.3

2.2

52.0

61.9

0.41

111

(3013862) HLA-DP [Type]

0.71

0.24

1.0

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

386

1.10

0.24

1.9

—

(3041354) Potassium [Moles/volume] in Venous blood

321

2430

1.04

0.24

2.7

2.4

4.1

mmol/l

0.01

321

2412

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

266

0.88

0.24

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

683

1.07

0.22

1.2

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

554

1.08

0.22

1.1

1.0

0.4

1.6

u/ml

1.19

156

(3033799) Differential panel - Peritoneal fluid

615

0.93

0.22

1.8

1.9

—

(3002719) Hemoglobin [Mass/volume] in Urine

1.22

0.22

1.0

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

159

1305

0.95

0.22

2.3

2.4

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

476

0.92

0.21

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

639

1.07

0.21

1.6

1.9

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

151

1128

1.05

0.21

1.0

2.1

3.1

u/ml

0.36

405

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

179

1.14

0.21

1.0

—

(3017950) Salicylates [Moles/volume] in Serum or Plasma

1.19

0.21

1.2

1.4

—

1078.4

umol/l

—

(3013293) Extractable nuclear Ab [Presence] in Serum

209

1.12

0.21

1.3

1.6

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

329

1.10

0.21

1.2

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

304

0.90

0.21

1.4

1.8

2.3

ug/l

1.30

185

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

0.20

0.0

1.0

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.20

0.0

1.0

—

(40762887) Creatinine [Moles/volume] in Blood

1.27

0.20

1.2

1.3

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

403

3243

0.97

0.20

1.4

191.8

177.5

pmol/l

0.13

388

3160

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.22

0.20

1.3

1.4

490.3

326.2

umol/24h

0.84

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

130

0.84

0.20

1.3

2.3

24.9

16.3

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

163

0.87

0.19

2.7

2.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

195

1587

0.96

0.19

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

195

1584

0.96

0.18

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1046

8077

1.02

0.18

1.3

1.2

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

212

1.11

0.17

1.2

2.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

333

0.92

0.17

1.0

1.1

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

0.74

0.17

1.6

1.1

196.8

179.4

ug/g

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.73

0.17

1.0

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

161

1.12

0.16

1.0

1.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

294

2245

1.03

0.16

3.9

4.8

329.5

362.3

umol/l

3.57

241

1903

(46236302) HLA-C [Type] by High resolution typing

0.75

0.15

1.0

—

(40760409) HLA-A [Type] by High resolution

0.75

0.15

1.0

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.75

0.15

1.5

1.3

—

(40760410) HLA-B [Type] by High resolution

0.75

0.15

1.0

—

(40763590) HLA-DQ beta [Type]

0.75

0.15

1.0

—

(3035933) Granulocytes/100 leukocytes in Blood

306

0.92

0.15

1.6

1.9

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

313

1.08

0.15

1.9

6.2

28.7

48.4

u/l

3.84

131

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.84

0.14

1.0

1.1

—

(3008037) Lactate [Moles/volume] in Venous blood

529

4217

0.98

0.14

4.1

3.2

1.6

1.7

mmol/l

1.54

519

4143

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

110

1.14

0.14

1.0

1.1

1.0

1.2

u/field

1.35

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

288

0.92

0.14

4.1

3.2

45.1

135.7

ng/l

2.48

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

345

1.07

0.13

1.7

2.0

1.2

10.6

ug/l

1.68

181

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

1.16

0.13

1.2

1.4

1.3

1.0

u/field

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.85

0.13

3.1

3.6

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

179

1.09

0.12

1.2

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

318

0.94

0.12

1.2

1.1

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

104

1.13

0.12

3.8

3.0

5.7

48.5

pmol/l

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

313

2405

1.02

0.12

2.7

2.4

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

142

1.10

0.11

1.1

1.3

0.3

u/ml

0.34

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

218

1.08

0.11

1.6

1.5

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

107

0.88

0.11

1.3

1.7

—

(3004775) Volume in Urine collected for unspecified duration

195

1565

0.98

0.11

2.5

2.2

633.5

688.1

1.26

126

1031

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

142

1081

1.03

0.11

1.6

1.3

73.5

71.4

pmol/l

0.06

330

(3014148) Varicella zoster virus Ab [Titer] in Serum

176

1346

1.02

0.10

1.2

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

308

2455

0.98

0.10

1.2

1.3

143.1

217.8

miu/ml

2.88

953

(40765096) Chromosome analysis panel by Banding

547

0.96

0.10

1.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

174

1.08

0.09

1.2

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

1.13

0.08

1.2

1.0

8.9

8.5

mmol/l

0.21

(3041806) Other cells [#/volume] in Blood by Manual count

0.80

0.08

1.4

1.3

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.12

0.08

1.6

1.5

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

0.82

0.07

1.0

1.1

1.5

1.3

u/field

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

0.80

0.07

1.0

1.1

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.87

0.07

2.6

6.5

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.86

0.07

1.3

3.2

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.84

0.07

1.0

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

115

1.09

0.07

1.1

1.0

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.08

0.07

1.3

1.1

338.4

268.6

nmol/l

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

618

0.98

0.05

1.8

11917.3

11075.3

e6/l

0.05

335

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

155

1.06

0.05

2.8

4.6

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

186

1.05

0.05

1.0

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

194

1.05

0.05

1.1

1.0

—

(40768806) Pleura Pathology biopsy report

282

2229

0.99

0.04

1.6

1.5

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.08

0.03

1.6

1.5

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

548

1.02

0.02

1.6

1.9

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.93

0.02

1.0

1.2

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

159

1.03

0.01

1.0

1.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

120

1.04

0.01

1.1

1.2

—

(3045142) Bone marrow Pathology biopsy report

266

2076

1.00

0.01

1.2

1.3

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

762

1.01

0.01

1.1

1.2

—

(3044007) Cell count panel - Peritoneal fluid

554

0.99

0.01

1.8

1.9

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

183

1.03

0.01

1.2

1.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

694

0.99

0.00

2.0

1.9

8205.3

2737.2

e6/l

0.43

470

(3017509) Phencyclidine [Presence] in Urine

1.06

0.00

1.6

1.5

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

106

0.96

0.00

2.0

2.7

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

431

1.00

0.00

1.6

1.3

135.5

25.8

g/l

0.51

345

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

302

0.99

0.00

1.1

1.2

—

(40758292) HTLV I+II Ab panel - Serum

240

1.01

0.00

1.4

1.5

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

125

983

1.00

0.00

5.9

6.4

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

311

1.01

0.00

2.3

2.8

140.0

1857.6

u/l

2.47

277

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

244

1.00

0.00

2.1

2.6

55.5

77.4

pmol/l

0.88

213

(3009220) Epithelial cells.squamous [#/volume] in Urine sediment

0.00

0.0

1.3

—

0.6

—

(3012932) Hazelnut IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

4.2

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

0.00

0.0

1.0

—

17.3

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.2

—

(3002853) Influenza virus B Ab [Titer] in Serum

0.00

0.0

1.0

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.00

0.00

1.0

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.91

0.00

1.0

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

1.00

0.00

1.2

3.4

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.93

0.00

1.0

1.2

—

mmol/l

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.88

0.00

5.7

5.9

406.1

423.5

umol/l

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

0.98

0.00

1.0

—

(3029396) Erythrocyte agglutination [Presence] in Blood

0.97

0.00

1.4

1.7

—

Mortality – FinRegistry

↥

Association

Association between endpoint M13_SPINSTENOSIS and mortality.

Females

Parameter	HR [95% CI]	p-value
M13_SPINSTENOSIS	1.009 [0.93, 1.09]	0.823
Birth year	0.999 [0.99, 1.01]	0.858

During the follow-up period (1.1.1998 — 31.12.2019), 17303 out of 73694 females with M13_SPINSTENOSIS died.

Males

Parameter	HR [95% CI]	p-value
M13_SPINSTENOSIS	1.151 [1.06, 1.25]	< 0.001
Birth year	0.988 [0.98, 1.0]	0.01

During the follow-up period (1.1.1998 — 31.12.2019), 16425 out of 59811 males with M13_SPINSTENOSIS died.

Mortality risk

Mortality risk for people of age

years, who have M13_SPINSTENOSIS.

N-year risk	Females	Males
1	0.103%	0.208%
5	0.654%	1.28%
10	1.645%	3.229%
15	3.206%	6.397%
20	5.688%	10.771%

Relationships between endpoints

↥

Index endpoint: M13_SPINSTENOSIS – Spinal stenosis

GWS hits: 57

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Spinal stenosis

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints